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The T-box transcription factor TBX18 is essential to mesenchymal cell differentiation in several 
tissues and Tbx18 loss-of-function results in dramatic organ malformations and perinatal lethality. 
Although the expression and function of Tbx18 has been analyzed in several tissues, the 
homozygous mutants die at birth, and the long-term effects of Tbx18 in cell development and 
differentiation have not been identified. Using a long-lived translocation mutant, 12Gso - a 
hypomorphic allele of Tbx18 caused due to disruption of the gene’s regulatory structure - we were 
able to circumvent the perinatal lethality and investigate adult phenotypes of Tbx18 deficiency. 
Upon studying the histopathology of 12Gso/Tbx18- mutant adults, unexpectedly severe defects 
were seen in the prostate. The prostate became an ideal system to study Tbx18’s role in postnatal 
development due to its non-essential nature, thus giving us the ability to create conditional mutants 
of Tbx18 in this tissue that survive to adulthood. 
 
Our studies demonstrated that Tbx18 is essential to the development of periductal smooth muscle 
stromal cells in prostate, particularly in the anterior lobe, with a clear impact on prostate health in 
adult mice. Prostate mesenchymal cells that fail to express Tbx18 do not condense normally into 
smooth muscle cells of the periductal prostatic stroma; these periductal stromal cells in mutant 
prostate assume a hypertrophic, myofibroblastic state and the adjacent epithelium becomes grossly 
disorganized. To identify molecular events preceding the onset of this pathology, we compared 
gene expression in the urogenital sinus (UGS), from which the prostate develops, in Tbx18-null 
and wild type littermates at two embryonic stages. Genes that regulate cell proliferation, smooth 
muscle differentiation, prostate epithelium development, and inflammatory response were 
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significantly dysregulated in the mutant urogenital sinus around the time that Tbx18 is first 
expressed in the wild type UGS, suggesting a direct role in regulating those genes.  
 
Our previous data indicated that the dynamic expression of Tbx18 is controlled by an expansive 
regulatory architecture, extending far upstream and downstream of the gene. We coupled 
circularized chromatin conformation capture (4C) and ATAC-seq from embryonic day 18.5 
(E18.5) mouse urogenital sinus (UGS), with the goal of identifying elements that interact with the 
Tbx18 promoter in developing prostate. The data revealed dozens of active chromatin elements 
distributed throughout a 1.5 million base pair topologically associating domain (TAD). To identify 
cell types contributing to this chromatin signal, we used lineage tracing methods with a Tbx18:Cre 
“knock-in” allele; these data show clearly that Tbx18-expressing precursors differentiate into wide 
array of cell types in multiple tissue compartments, most of which had not been previously 
reported. We also used a 209 kb Cre-expressing Tbx18 transgene (Tbx18:BAC-iCre), to partition 
enhancers for specific precursor types into two rough spatial domains.  
 
RNA-seq studies of the developing UGS revealed expression of the zinc-finger transcription factor 
Wt1, a gene previously unreported to be expressed in the prostate and a known interaction partner 
of Tbx18. Furthermore, Wt1 was significantly dysregulated in Tbx18-/- mutant UGS indicating a 
relationship between the two genes in this tissue. After establishing high expression of Wt1 in the 
developing UGS and tracing the cell lineages arising from Wt1-expressing precursor cells, we 
obtained a conditional knockout mutation of the Wt1 gene and tested the effects of Wt1 loss of 
function in prostate development.  Crossing the conditional mutants with animals carrying a 
prostate-specific Cre allele, we identified a severe over-proliferative phenotype in the prostate of 
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the conditional Wt1 knockouts. To identify transcriptional targets of this TF, we performed WT1 
chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq) in UGS 
chromatin using a tested WT1 antibody.  The data revealed a role for Wt1 upstream of the 
TGFβ/BMP pathway during prostate development, a signaling pathway known to inhibit over-
proliferation of epithelial cells.   Whereas WT1 has been known for some time to be dysregulated 
in human prostate cancer, its function in the normal prostate has not previously been described. 
This study has thus revealed a new role for the very well-studied WT1 protein, as a transcription 
factor with a key function in prostate development, and one with clear relevance to a potential link 
to prostate cancer in adults. 
 
This thesis uses a combination of traditional cell biology approaches along with functional 
genomics strategies to study the expression and function of the transcription factors, Tbx18 and 
Wt1, in prostate development for the first time. Using mouse genetics, we generate conditional 
mutants to identify histo-pathologies associated with the loss-of-function of these genes in the 
prostate. RNA-seq and ChIP-seq are also used to identify molecular targets and pathways 
downstream to these TFs. Finally, ATAC-seq and 4C are used to map the extended regulatory 
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Development is the result of a complex but tightly controlled regulation of transcriptional 
networks, leading to organogenesis and growth. The expression of genes is firmly orchestrated, 
both spatially and temporally, leading to very specific paths of cellular differentiation, fates and 
lineages. Over the years, studies have shown the tremendous importance of Transcription Factors 
(TFs) in multiple facets of development, an excellent example of which are the Pioneer factors 
(Pax7, FoxA and others). The gestational period of a mouse (Mus musculus) is a mere nineteen 
days, during which the embryo develops and then continues into postnatal life. The development 
of the different organs and tissues in the embryo happens in parallel, facilitated by distinct TFs 
that act together in a synchronous way. This thesis describes a small but essential fraction of the 
expansive TF network that contributes significantly to mouse prostate development, differentiation 
and function, starting during prenatal development and continuing after birth. The central player 
of the story is the T-box TF, Tbx18, and our study is focused on how the regulation of this gene is 
required for the right course of development in the prostate and supporting tissues. The study of 
this TF in the prostate describes a novel role of the gene in development, including fates of the 
gene in novel cell specifications. During our study investigating Tbx18, the zinc finger 
transcription factor Wt1, a previously implicated regulatory partner of Tbx18, emerged as another 
crucial player of prostate development and function. The regulatory dynamics of these two TFs in 
prostate development is the focus of this thesis with an emphasis on tracking cell fates and lineages 




1.1 T-BOX FAMILY OF TRANSCRIPTION FACTORS 
The T-box family of transcription factors are a group of more than 18 transcription factors that 
have varied but crucial functions in development of all animal species (Papaioannou, 2001). The 
members are important in the development of multiple organ systems, are upstream of major 
signaling pathways, and affect different stages of development with function depending largely on 
tissue context (reviewed by (Papaioannou, 2014)). The T-box family especially play key roles in 
early development, including gastrulation and somite patterning, organogenesis and limb 
development. The founding member, Brachyury, also known as T, was the first member to 
discovered and characterized, and mutations in this gene causes short tails in heterozygotes, and 
embryonic lethality in homozygotic mice (Kispert and Herrmann, 1993, Kispert et al., 1995).  
 
The conserved T-box domain, present in all members, is a 180-200 amino acid polypeptide 
sequence that recognizes and binds to sequence-specific DNA at a consensus half site 
(AGGTGTGAAA), known as the T-box binding element (TBE) (Sun et al., 2004) (Fig. 1.1).  Some 
T-box members have also have shown to bind to other non-canonical binding motifs, for example, 
is Tbx20 binds a TBS-related but novel motif in the heart (Boogerd et al., 2016, Shen et al., 2011) 
(Fig. 1.1). The target recognition depends on the gene, on the tissue in which the protein is 
expressed, and interaction with other proteins or cofactors. T-box proteins have been shown to 
interact with several TFs and co-factors, including homeobox transcription factors (Hiroi et al., 
2001).   
 
In addition to transcriptional regulation, T-box genes are implicated in other functions suggesting 
that this group of TFs is versatile in nature. T-box members have been shown to mediate histone 
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H3 lysine 27 methylation (Lu et al., 2011) and recruit methyltransferase activity at target sequences 
(Miller et al., 2008).  This suggests epigenetic regulatory activity that could be an important 
component of the proteins’ transcription regulation functions. RNA-binding proteins have also 
been identified as interacting partners to some T-box proteins, and some T-box proteins directly 
bind to RNA through the TBE (Kumar et al., 2014). Clearly, there is more to be learned about 
these genes and their function through a complex interaction network of targets genes, co-factor 
and other partner proteins. These functions are also dependent on tissue context and time of 
development.    
 
1.2 TBX18 DURING DEVELOPMENT 
Tbx18 is a member of the previously described ancient T-box family that is expressed early during 
the development of the embryo and is expressed in a wide array of cell types (Fig. 1.2A) with 
essential functions in the development of multiple organs. Tbx18 functions are particularly well 
studied in the differentiation of mesenchymal cells, most often (but not always) driving 
differentiation into some form of smooth muscle. However, the gene plays a role in development 
of diverse cell types and tissues, being essential to the formation of the axial skeleton (Bussen et 
al., 2004), the ureter (Airik et al., 2006), and the sinoatrial node and venous return system in the 
heart (Cai et al., 2008). The Tbx18 null mutant (Tbx18-/-) mouse dies shortly after birth with 
uninflated lungs suggesting respiratory failure (Bussen et al., 2004), possibly due to abnormal 
development of the pleuropericardial membranes (Norden et al., 2012). But our studies suggest 
that a more complex failure of different cell types, like improper tissue innervations (Chapter 3), 
that could result in the premature death. Tbx18 is also required for proper vertebrae formation, 
playing a key role in early separation of anterior and posterior somite compartments (Bussen et 
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al., 2004). Additional functions with subtle phenotypes have also been described in the ear (Trowe 
et al., 2008), skin (Grisanti et al., 2013), and kidney (Xu et al., 2014).  
 
Tbx18-/- mice exhibit gross defects in external morphology, including the fact that the Tbx18−/− 
pup has a shorter body axis than the wildtype (Figs. 1.2B and 1.2C). The null mice also exhibit 
morphological defects in the epicardium and coronary vessels, with epicardial cells showing 
impaired proliferation and increased apoptosis, and coronary vessels exhibiting abnormal 
patterning and blood-flow capacity (Wu et al., 2013). Tbx18 also regulates myocardial 
differentiation during cardiogenesis (Greulich et al., 2012). The ureteral mesenchyme in the 
Tbx18-/- embryos fail to condense around the distal ureteral epithelium and as a result, the inner 
smooth muscle layer fails to form (Airik et al., 2006). The ureteral epithelium relies on the stroma 
for juxtracrine M-E signaling, does not proliferate sufficiently and becomes thin and weakened. 
All of these data clearly indicate that Tbx18 is essential to differentiation of a variety of cell types. 
However, as Tbx18-/- mutants do not survive past birth, it is difficult to characterize postnatal 
phenotypes and understand the severity of organ function defects. The data on molecular roles of 
Tbx18, like signaling pathways it affects and target gene activation/repression, is also greatly 
lacking. Hence to fully understand the role of this TF studies need to be performed of phenotypes 
of Tbx18 knockouts early in development, but also on conditional mutants, later in adults using 
histopathology. Additionally, molecular roles of this gene need be studied using functional 
genomics to reveal targets, interacting partners and the regulatory domains that control the 





1.3 12GSO, A TRANSLOCATION MOUSE MUTANT 
12Gso is a mouse T(4;9) reciprocal translocation corresponding to a clean breakage-and-reunion 
event located at Chromosomes 4 and 9 (Bolt et al., 2014). The 12Gso mutation arose in the 
offspring of male mice treated with bis-acrylamide, a treatment that has been used to generate 
translocations at high frequencies (Culiat et al., 1997). Heterozygous 12Gso (12Gso/+) animals 
are completely normal and fertile with no apparent morphological defects. However, 12Gso 
homozygotes (12Gso/12Gso) display physical deformities including spinal abnormalities and 
sometimes tail kinks, are shorter in stature (Fig. 1.3A) but can survive to adulthood. The animals 
often display hydronephrosis as adults (Bolt et al., 2014). The 12Gso chr 4 breakpoint was mapped 
to the intronic region of the Abca1 gene, and in chr9 was located 78kbp downstream of Tbx18 (Fig. 
1.3B). Through complementation tests and qPCR analysis, 12Gso was determined to be a 
hypomorphic allele of Tbx18 associated with reduced expression of Tbx18, but not complete loss, 
hence resulting in the longevity of the homozygous animals (Bolt et al., 2014).  
 
The compound heterozygous animals generated in a cross between 12Gso and Tbx18 KO animals 
(12Gso/+, Tbx18-/+, abbreviated henceforth 12Gso/Tbx18-) were also able to live and survive to 
adulthood, and these animals were used to study deficiency of Tbx18 in adults. The molecular and 
phenotypic characterization of 12Gso/12Gso, and the compound heterozygotes, 12Gso/Tbx18- 
revealed similarities to the Tbx18-/- animals; all three genotypes were associated with spinal 
abnormalities and severe kidney and ureter defects in adults (Bolt et al., 2014). However, neither 
the 12Gso/12Gso nor the 12Gso/Tbx18- animals are generated efficiently. Fortunately, conditional 
(Lox-flanked, or floxed) Tbx18 mutants were made available to us, allowing the long-term effects 
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of Tbx18 deficiency in specific cell types to be studied efficiently through crosses to cell type-
specific Cre alleles. 
 
The chr9 breakpoint in the 12Gso animal is located within a “gene desert” located 78 kbp 
downstream of Tbx18 and 105kbp of the Tbx18 promoter.  Gene deserts are defined as long regions 
containing no protein-coding sequences and without obvious biological functions. But as the HiC 
maps have revealed complex 3-D arrangements of the genome where long distance regions come 
into contact by forming loops, every region on the genome seems to have significance (Nobrega, 
2003, Ovcharenko et al., 2005). As 12Gso is a hypomorphic allele of Tbx18, we hypothesized that 
the break in chr9 in this mutant separated essential regulatory elements from the promoter of the 
gene, resulting in the reduced expression in specific tissues and cell types.  Published studies with 
a Tbx18 bacterial artificial chromosome (BAC) reporter transgene (Wang et al., 2009) further 
indicated that essential enhancers required for ureter expression would be located close to the 
breakpoint site. The 12Gso translocation breaks within a cluster of highly conserved sequences 
roughly 4.5kbp in length that was called ECR1 (Fig. 1.3C) (Bolt et al., 2014), and a transgenic 
reporter created from this region and injected into the genome of transgenic mice confirmed that 
ECR1 includes a Tbx18 ureter enhancer. ECR1 has high expression in the urogenital tract, 
suggesting that it is an enhancer for expression of Tbx18 in these cell types. Location of the 12Gso 
breakpoint and ECR1 indicated that Tbx18 is controlled by sequences spread over a vast and 
extended regulatory domain. The extent and landscape of this regulatory domain and how the gene 




During histopathological analysis of 12Gso/Tbx18- adult animals, one of the most prominent 
defects was found in the prostate. The anterior prostatic epithelial cells were disorganized and had 
lost cellular organizational structure, while the stroma was thicker than usual (Chapter 2). Tbx18 
had not previously been shown to be expressed or functional in the prostate and the defect brought 
into light a novel role of this gene in this organ. The prostate is a non-essential tissue but is essential 
in males for reproduction. It is prone to pathological complications like benign tumors and 
prostatitis in adult males that can lead to immense discomfort. Studying the function of Tbx18 in 
the prostate is well suited as generation of conditional knockouts of Tbx18 in this non-essential 
tissue that are long lived is possible, and thus we can study the postnatal effects of the gene. The 
role of Tbx18 in cellular differentiation of the prostate and associated tissues can then be used as 
model to examine the role of this gene in other essential organs in which this multi-faceted gene 
is expressed.   
 
1.4 WT1 DURING DEVELOPMENT 
The Wilms’ tumor 1 (Wt1) transcription factor was first identified for its role in Wilms’ tumors, a 
type of childhood kidney tumor (Call et al., 1990, Gessler et al., 1990). Since then it’s role in the 
development of the kidney (Stark et al., 1994, Kreidberg et al., 1993), gonads (Bandiera et al., 
2015) and the heart (Martinez-Estrada et al., 2010) have emerged to be necessary and crucial. Like 
Tbx18, Wt1 is expressed highly during development of multiple tissues, including the mesothelium 
(Chau and Hastie, 2012) but remains on in adults in certain organs and helps with tissue 
homeostasis (Chau et al., 2011). A role in prostate development has never been described, even 
though WT1 misexpression has been implicated in prostate cancer (Fraizer et al., 2016, Devilard 
et al., 2006) and expression in the UGM mesenchyme in the human embryo has been described 
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(Kohler et al., 2007). In the embryonic epicardium, Tbx18 and Wt1 are co-expressed (Norden et 
al., 2012).  Takeichi and colleagues (Takeichi et al., 2013) showed that in primary epicardial cells 
derived from E12.5, Tbx18 and Wt1 play coordinated and antagonistic roles in the regulation of 
epicardial epithelial-mesenchymal transition (EMT). Specifically, Tbx18 and Wt1 bind to the 
promoters of Slug and Snail, TFs well characterized to promote EMT (Medici et al., 2008).  While 
Tbx18 maintains expression of Slug and promotes EMT, Wt1 suppresses Slug expression and 
inhibits EMT. This study hypothesized that Tbx18 and Wt1 control the epithelial-mesenchymal 
balance by fine-tuning Slug expression, coordinating together and not working individually 
(Takeichi et al., 2013).  
 
Although EMT has not been implicated in prostate development, the prostate also has 
mesenchymal and epithelial cells in close apposition and the balance and interactions between 
these compartments is very important during their development and in maintaining tissue 
homeostasis. In RNA-seq analysis of Tbx18-/- UGS at E18.5, we found to our surprise that Wt1 
was significantly upregulated. This suggested, for the first time, that Wt1 was expressed in the 
UGS, which had never been investigated before.  Furthermore, the data indicated that Wt1 
expression was related to Tbx18 expression in this tissue, either in a direct or indirect way. Because 
of the important roles of Wt1 in development and homeostasis of many tissues, and because of the 
known interactions between Wt1 and Tbx18, we became interested in studying the function of Wt1 
in prostate development (Chapter 4), and its relation to Tbx18 during development in this tissue. 
On examination of Wt1-/+ heterozygous animals we noticed mild prostate defects in adults 
(Chapter 4). As Wt1-/- animals don’t survive beyond E12 (Martinez-Estrada et al., 2010), we 
obtained a conditional mutant (a kind gift of Dr. Nick Hastie, MRC Edinburgh) and created 
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conditional knockouts of Wt1 in the prostate using Cre-Lox (Chapter 4). As predicted, these 
conditional Wt1 homozygous mutants display severe defects in prostate morphology with loss of 
organization of the epithelial compartment. Chapter 4 of this thesis will describe the 
histopathology of these prostates and the molecular role of Wt1 in UGS and later prostate 
development. 
 
1.5 MOUSE UROGENITAL SINUS (UGS) DEVELOPMENT 
The prostate is an accessory male reproductive organ located at the base of the bladder and 
produces the bulk of the seminal fluid. Growth and development of the prostate begins 
embryonically and completes at sexual maturity (Fig. 1.4). It develops from the Urogenital sinus 
(UGS), an endodermal cavity derived from the cloaca. The development of the prostate can be 
categorized into 5 distinct chronological stages: 1. Determination, 2. Initiation or Budding, 3. 
Branching morphogenesis, 4. Differentiation, and 5. Pubertal maturation (Prins and Putz, 2008). 
Expression of Tbx18 is seen during UGS development during a short window, but effects of Tbx18 
depletion is seen as a severe defect very prominently in adults. Our understanding of the role of 
Tbx18 brings into light how the deletion of a single gene can bring about compounded series of 
flaws in signaling pathways, cellular differentiation and tissue morphogenesis (Chapter 2). 
 
Determination occurs when a definitive UGS is formed by embryonic day 12.5 (E12.5) located 
caudal to the neck of the bladder, surrounding the urethra (Fig. 1.4). The male and female UGS 
are morphologically indistinguishable at this point. Molecular signals commit this set of cells to a 
specific prostatic cell fate (Fig. 1.5). The UGS consists of 2 compartments: Urogenital epithelium 
(UGE) surrounded by the Urogenital mesenchyme (UGM). In the next stage of Initiation or 
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Budding, between embryonic days 16.5-17.5 (E16.5-E17.5), there is outgrowth of epithelial buds 
from the UGE into the surrounding UGM (Marker et al., 2003) (Fig. 1.4). This is triggered only in 
males by circulating androgens from the fetal testes, making the UGS in males distinguishable in 
morphology from females. Branching morphogenesis begins when the multiplying buds contact 
the mesenchymal pads leading to elongation of the buds in secondary, tertiary and further branch 
points occurring at the distal tips (Donjacour and Cunha, 1988) (Fig. 1.4). Differentiation is 
coordinated with the Branching morphogenesis and occurs in proximal-to-distal direction where 
the epithelium and mesenchyme differentiate into specific cell types (Hayward et al., 1996a) (Fig. 
1.5). This epithelial and mesenchymal cyto-differentiation occurs 2-3 weeks after birth. At 
puberty, the serum testosterone levels rise significantly, and the wet weight of the prostate 
increases and the tissue starts to secrete prostate specific proteins.  
 
At sexual maturity the mouse prostate contains 4 lobes that have distinct ductal morphology: 
ventral, dorsal, lateral and anterior (Oliveira et al., 2016) (Fig. 1.4). The lobes are surrounded by a 
thin mesothelial layer that also contains adipose tissue, nerves and blood vessels. The ventral lobe 
has moderate to large acini containing simple epithelial cells that have the least amount of infolding 
surrounded by a thin fibromuscular stroma. The dorsal lobe has small acini containing columnar 
epithelium and moderate infolding surrounded by dense stroma. The lateral lobe consists of flat 
luminal surface lined by cuboidal to low columnar epithelial cells that contain very little infolding. 
The dorsal and lateral lobes are often grouped together as the dorso-lateral lobes due to similar 
ductal systems. The anterior lobe (often known as the coagulating gland) is the largest 
characterized by complex acini lined by cuboidal to columnar epithelial cells surrounded by a 
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prominent fibromuscular layer. Each individual lobe contributes certain specific proteins to the 
seminal fluid that is needed its potency (Cunha et al., 1987, Fujimoto et al., 2006).  
 
In contrast the human prostate is divided into three major zones that are distinct histologically: 
central, peripheral and transitional (McNeal, 1984). Although there are significant differences in 
anatomy and histology of mouse and human prostates they perform the same function during 
reproduction and have the similar cellular compositions and signaling interactions (Aaron et al., 
2016). The ductal morphogenesis also occurs in an analogous manner. The murine prostate can 
thus be used as a model to study prostate development and disease (Ittmann, 2018). 
 
1.6 CELL TYPES AND LINEAGES IN PROSTATE AND ASSOCIATED TISSUES 
The prostate proper is grossly divided into 2 compartments, mentioned before: urogenital 
epithelium (UGE) that differentiates into prostatic epithelium and urogenital mesenchyme (UGM) 
that differentiates into stroma. Each of these compartments contain a distinct cellular signature and 
differentiation pattern. Additionally, there are other cellular structures that are closely associated 
with the prostate that mediate its growth and function, many of which have differentiated from the 
UGS. Lineages of Tbx18 are seen in many of these diverse cell types and the defects in the Tbx18 
knockout prostate are most likely due to impairment of multiple, if not all, differentiation pathways 
(Chapter 3). Hence it is imperative to understand the development and differentiation pathways of 
these cell types to understand the roles of Tbx18 in them. 
 
The prostate epithelium (Fig. 1.6A) contains secretory luminal cells that make up the bulk of the 
compartment and beneath them lie basal cells. The luminal cells generate most of the secreted 
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proteins in the prostatic fluid (Marker et al., 2003) and the basal cells maintain epithelial structure 
and integrity (Kurita et al., 2004). Rare neuroendocrine cells also present, although whose role are 
not clearly understood but are thought to play a similar role as neuroendocrine cells in other organs 
like the intestine where they regulate tissue growth, differentiation and secretory activity (Cox, 
2016). Neuroendocrine cells are hypothesized to have origins in the neural crest (Szczyrba et al., 
2017), that is different from luminal and basal cells that originate from the UGE. The epithelium 
gained considerable interest in the past due to the primary site of prostate cancer, but studies have 
now shown the contribution of the stroma and other cell types to cancer (Shen and Abate-Shen, 
2010). The prostate stroma surrounds the epithelial basement membrane, consisting of smooth 
muscle cells (SMCs) and fibroblasts (Fig. 1.6A). These cells originate from the loose mesenchyme 
of the UGS that is derived from the mesoderm. The development of the prostate is highly 
dependent on mesenchymal-epithelial interactions via reciprocal paracrine signaling between 
these compartments (Marker et al., 2003). Each compartment relies on the proper differentiation 
of the other for normal development. 
 
The rhabdosphincter is a striated muscular structure present as a ring at the neck of the bladder 
(Fig. 1.6B) in both males and females that is important for urinary continence. In males, the 
prostatic buds push out of this muscle during branching morphogenesis and in adults the prostate 
surround this muscle (Hinata and Murakami, 2014). The origins of this muscle is still controversial 
although it is hypothesized that this muscle is derived from smooth muscle cells of the prostate 
which is unlike any other skeletal muscle in the body (Borirakchanyavat et al., 1997). Around the 
prostate lies a layer of fat called periprostatic adipose tissue (PPAT). PPAT is thought to be an 
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endocrine tissue that secretes and is responsive to hormonal activity, although little is known about 
its origin (Alexandre et al., 2018). 
 
The functional activity of the prostate is under hormonal and neuronal control. Autonomic nerves 
innervate the tissue that control the release of hormones, regulate renal blood flow, peristalsis of 
urine, coordination of urine release and sexual arousal (Fig. 1.6D). A dual sympathetic and 
parasympathetic innervation (McVary et al., 1998, McVary et al., 1994) is mediated through the 
pelvic ganglia located in close proximity to the growing UGS (Keast, 2006, Keast, 1999, Yan and 
Keast, 2008). The pelvic ganglia (PG) receive input from the lumbar (sympathetic) and sacral 
(parasympathetic) preganglionic axons (Keast, 1995). The PG contains differentiated neurons and 
satellite glia that envelope and support the neurons. Most pelvic ganglion neurons are either 
cholinergic (marked by Vesicular acetylcholine transporter- VaCht) or noradrenergic (marked by 
Tyrosine hydrolase- TH) (Wiese et al., 2012b). Additionally, the PG also innervates the 
rhabdospincter to mediate its function of urinary continence.  
 
The expression window of Tbx18 is between E16-P8 in the developing UGS (Chapter 2). During 
this time, many of the mesenchymal cells start to differentiate into their respective lineages such 
as smooth muscle, fibroblasts, smooth muscle and the rhabdospincter. Tbx18 is expressed in 
undifferentiated mesenchymal cells and our data shows that it is needed for specific differentiation 
fates (Chapters 2,3). Tbx18 is known to play a key role in smooth muscle differentiation (Ikeda et 





1.7 AIMS AND SCOPE OF THIS THESIS 
The development of the prostate is a highly regulated process which involves multiple genes and 
pathways, and the paracrine signals between different cell types and compartments. Using the 
prostate as a tissue of choice, this thesis aims to reveal the role and function of the TFs Tbx18 and 
Wt1 during its development. Histopathology of conditional mouse mutants have been used to 
understand morphological defects in the prostates of Tbx18 and Wt1 mutants. Functional genomics 
have been used to identify regulatory regions, molecular targets and involvement in signaling 
pathways of these genes. Immunohistochemistry and lineage tracing assays have been used to 
identify cell fates of TBX18+ and WT1+ cells and their respective differentiation paths.  
 
Chapter 2 of this thesis describes the molecular role of Tbx18 in prostate development. Expression 
of this developmentally active TF is shown in the UGS for the first time. Using the translocation 
mutant 12Gso, previously described by work from our lab (Bolt et al., 2014), we are able to study 
histopathological defects of adult Tbx18 mutant prostates, specifically in the anterior lobe. We 
show that Tbx18 is essential to the differentiation and maintenance of the mesenchyme and in the 
mutants the smooth muscle cells do not differentiate normally. 
 
Chapter 3 describes the regulatory regions of Tbx18 that controls the spatial expression of the gene 
in certain cell types. Prior work done in the lab indicated that Tbx18 has an extended regulatory 
landscape that drives its expression of the gene (Bolt et al., 2014). Using Tbx18 promoter as a 
view-point, we performed 4C-seq and ATAC-seq to identify a 1 MB region around the locus that 
is conformationally active. An extensive lineage tracing assay was performed to show the cell fates 
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of TBX18+ cells. We are also able sub-divide the regulatory domain using a Cre allele expressing 
Tbx18 only by a subset of the regulatory region. 
 
Chapter 4 investigates the role of Wt1 during prostate development. Expression and lineages of 
Wt1 during UGS development are shown for the first time. The Wt1 conditional knockout animals 
have defects in the ventral and dorso-lateral prostate lobes in the epithelial compartment. To 
identify molecular targets of the gene, we performed WT1 ChIP-seq and RNA-seq of Wt1-/+ in 
the UGS. 
 
Chapter 5 summarizes and discusses the results of the previous chapters. A very interesting finding 
of this work was expression of Tbx18 and Wt1 in the dorsal root ganglia (DRG) neurons, located 
in the dorsal root of the spinal nerve. Preliminary data indicates that Tbx18 is necessary for the 
differentiation of neuroblasts located in the DRG into neurons and satellite glia cells. Future 
directions of this project are aimed to elucidate the roles of both these genes in the development 









Figure 1.1 (A) This figure has been adapted from (Papaioannou, 2014). Phylogenetic analysis of 
the T-box family reveals the Tbx1 subfamily that are closely associated in structure and are 
expressed in very similar tissue types. Tbx15 and Tbx18 very closely related and diverged around 
the same time during evolution. Other members that are closest to structure and function to Tbx18 
are Tbx22, Tbx1, Tbx10 and Tbx20. (B) The canonical T-box binding motif is well characterized 
and almost all the T-box TFs recognize DNA at this site. From PDB. (C) Tbx20, belonging to the 
same sub-family as Tbx18 has been shown to bind to a non-canonical binding motif (Shen et al., 







Figure 1.2 (A) In situ hybridization analysis of whole wild-type embryo at E9.5 for Tbx18 shows 
high expression of the gene in multiple cell types of the developing embryo. (B,C) Gross external 
defects in Tbx18-/- animals compared to wild-type.  Adapted from (Bussen et al., 2004) and 






Figure 1.3 12Gso/Tbx18- mutants survive to adulthood (A), animals pictured here are 3wks old. 
12Gso is reciprocal translocation mutation with a breakage-and-reunion event at chr4 and chr9 
(B). Chr9’s break is located 105kbp downstream of Tbx18 at a 4.5kbp conserved region called 






Figure 1.4 Prostate development in mice timeline. At the determination stage of prostate 
development, a definitive UGS is formed at embryonic day 12 (E12) located at the base of the 
bladder (A). Initiation of buds occurs from E16.5- E17.5 where epithelial cells grow into the 
surrounding mesenchyme (B). Panel B is a transverse section of the lower abdomen containing the 
UGS. Branching and differentiation of the UGS continues postnatally and the prostate extends in 
all directions outwards from the urethra (C). In adult mice the 4 distinct lobes can be distinguished 
by size and ductal morphology (D). Abbreviations: UGS- urogenital sinus, AP- anterior prostate, 
DLP- dorso-lateral prostate, VP- ventral prostate, UR- urethra. This figure has been compiled using 







Figure 1.5 Stages of prostate development. Ductal growth of the prostate is represented by the 
panels on the outer most edges. The central panel depicts the direction of growth and differentiation 
of cells in the mesenchyme and epithelium. Key signaling between mesenchyme and epithelium 
control development of the other compartment. Adapted from (Sugimura et al., 1986) and (Marker 





Figure 1.6 Cell types and structures in prostate and associated tissues. The adult prostate is a 
vast tissue with many cell types and structures, as shown in the hematoxylin and eosin stain. The 
prostate proper consists of 2 compartments: epithelium that contains luminal, basal and 
neuroendocrine cells; and stroma that contains smooth muscle and fibroblasts (A). A thick 
muscular layer called the rhabdospincter is seen as a ring right around the neck of the bladder (B). 
A layer of fat surrounds the prostate called the periprostatic adipose tissue (PPAT) (C). Autonomic 
nerves innervate the tissue through the pelvic ganglia that is located at close proximity to the UGS 
(D). Abbreviations: b- bladder; bv- blood vessel; hg: hypogastric nerve; pg- pelvic ganglia; u- 




TBX18 REGULATES THE DIFFERENTIATION OF PERIDUCTAL 
SMOOTH MUSCLE STROMA AND THE MAINTENANCE OF 
EPITHELIAL INTEGRITY IN THE PROSTATE 
 
2.1 INTRODUCTION 
During middle and late gestation of the mouse, the T-box transcription factor (TF) TBX18 is 
expressed in a population of m1esenchymal cells in the lower embryonic abdomen. These cells 
contribute to the stromal layer of nearly every organ in the urogenital system but with differing 
affects in each of them (Bohnenpoll et al., 2013). In the ureter, Tbx18 is essential to the formation 
of a coordinated smooth muscle layer that can conduct urine from the kidney to the bladder. 
Beginning at embryonic day 11.5 (E11.5) Tbx18-expressing mesenchymal cells begin to coalesce 
around the nascent ureter epithelial duct (Airik et al., 2006). Secreted SHH and WNT signals from 
the ureter epithelium maintain the proliferation and eventual differentiation of these Tbx18-
positive condensing mesenchymal cells (Trowe et al., 2012, Haraguchi et al., 2012, Bolt et al., 
2014). However, in the absence of Tbx18, the mesenchymal cells fail to respond to the epithelial 
signals and subsequently retire to a fibrocytic fate (Airik et al., 2006). Consequently, a still 
unknown signal acting downstream of Tbx18 in the mesenchyme, which normally reciprocates the 
proliferation signal to the ureter epithelium, fails to be activated. Due to the loss of these inter-
dependent signaling mechanisms, neither the ureter epithelium nor the stroma proliferates 
                                                 




sufficiently resulting in a ureter of reduced length, thickness, and elasticity. The consequent fluid 
build-up leads to a grotesque enlargement of both the ureters and kidneys in Tbx18 mutants (Airik 
et al., 2006, Bolt et al., 2014). 
 
Toward the posterior end of the urogenital system, the prostate is an organ essential to male fertility 
that arises developmentally from the urogenital sinus (UGS) (Sugimura et al., 1986). Beginning at 
E16.5, the urogenital sinus mesenchyme (UGS-M) begins differentiating under the influence of 
testicular androgens and then induces the adjacent urogenital sinus epithelium (UGS-E) towards a 
path of prostate committal (Sugimura et al., 1986, Cai et al., 2013). The naïve UGS-E, responding 
to signals emanating from the UGS-M, begins to invade the adjacent undifferentiated mesenchyme 
beginning around E17.5 (Zhu et al., 2007, Zhang et al., 2008b, Grishina et al., 2005, Lai et al., 
2012). As the epithelial buds extend into and beyond the UGS-M, mesenchymal cells condense 
around the buds producing the early rudiments of the prostate stromal layer, comprised mostly of 
smooth muscle cells and fibroblasts (Nemeth and Lee, 1996). Paracrine signals including Wnt 
(Mehta et al., 2011, Simons et al., 2012), Notch (Wu et al., 2011), Bmp (Grishina et al., 2005, 
Nemeth and Lee, 1996), Tgfb (Akhmetshina et al., 2012, Untergasser et al., 2005) and Shh 
(Podlasek et al., 1999, Doles et al., 2006) play critical roles in this process of prostate bud induction 
and differentiation, each with regional expression patterns and differential affects on the formation 
of the various lobes. Furthermore, abnormal expression of these factors and their downstream 
receptor pathways are indicative, and sometimes directly causative, of lobe specific prostate 
pathologies such as fibrosis and neoplasias (Akhmetshina et al., 2012, Schweizer et al., 2008, 




In the adult mouse prostate, the prostatic lobe stroma adjacent to the urethra consists of a core of 
smooth muscle cells (SMCs) with a few VIM+ fibroblasts positioned at the lobe perimeter (Peng 
et al., 2013, Peng and Joyner, 2015). The well-organized smooth muscle bundles produce large 
amounts of Tgfb1, which inhibits proliferation of the adjacent epithelial stem cell population; the 
loss of Tgfb1 signaling induces epithelial neoplasias (Tsujimura et al., 2002, Bhowmick, 2004). 
Paradoxically, in prostatic models of “reactive stroma”, SMCs and fibroblasts in the stroma 
experience up-regulation of Tgfb1 production resulting in progressive induction of the stroma 
towards a diseased myofibroblast phenotype (Untergasser et al., 2005, Tuxhorn et al., 2002). These 
myofibroblasts, distinguished by co-expression of SMA and Vimentin (VIM), exhibit elevated 
production of ECM components (collagens), Transforming growth factors (Tgfb1), and matrix 
remodeling enzymes (Serpines and Cathepins) to create a growth-promoting 
microenvironment(Yang et al., 2014). Because of these changes in the stromal microenvironment, 
the adjacent epithelium experiences hyper-proliferation and can become invasive (Wu et al., 2011, 
Untergasser et al., 2005, Bhowmick, 2004, Tuxhorn et al., 2001). A common outcome from this 
situation is the formation of Prostatic Intraepithelial Neoplasia (PIN) (Grabowska et al., 2014). 
 
Several studies have indicated that Tbx18 contributes to urogenital structures aside from the ureter 
and bladder (Bohnenpoll et al., 2013, Wang et al., 2009, Blum et al., 2010). However, since Tbx18-
null animals die perinatally (Bussen et al., 2004), phenotypic effects in the post-natally developing 
prostate have been impossible to discern. We recently reported a novel hypomorphic cis-regulatory 
mutation of Tbx18, called 12Gso (Bolt et al., 2014), and the relative longevity of these animals 
offered the opportunity to examine Tbx18-related postnatal phenotypes. Using this mutant in 
combination with a novel Tbx18 conditional allele, here we demonstrate that Tbx18 regulates 
25 
 
differentiation of a SMC subpopulation that contribute to the periductal prostate stroma, 
particularly within the mouse anterior lobe. In contrast to the ureter, which displays reduced 
stromal and epithelial thickness in mutant animals, periductal stroma proximal to the urethra is 
hypertrophied in Tbx18 mutant adult prostates, composed primarily of enlarged and disoriented 
SMCs and myofibroblasts. Furthermore, prostatic epithelial cells surrounded by this abnormal 
stroma are significantly disorganized by early adulthood, and the abnormal ductal regions also 
contain unusually large numbers of disorganized, Vimentin-positive cells. Together, our data 
indicate an important role for Tbx18 in regulating the reciprocal epithelial-stromal signaling from 
the earliest stages of prostate development, with implications for human prostate disease. 
 
2.2 MATERIALS AND METHODS 
2.2.1 Histopathology and Immunohistochemistry. 
Tissues were dissected at the appropriate gestational or postnatal stage. Tissues were fixed in 4% 
PFA at 4ºC, dehydrated, and embedded in paraffin wax for sectioning. 4-6μm sections were used 
in all experiments. TBX18-2 antibody is used at 1:800 in normal goat serum blocking solution and 
incubated overnight at 4ºC. Following washes, a Goat anti-Rabbit:HRP (Jackson ImmunoResearch 
111-035-003 1:500) secondary antibody was applied for 1hr at room temperature. Sections were 
covered in TSA-Rhodamine for 6 minutes then washed and counter stained with Hoecsht 33342. 
Commercial antibodies are VIM (Abcam ab92547 1:500), CK8 (ab53280 1:100), CK5 (ab24647 
1:750), and SMA (ab7817 1:75, ab5694 1:1000) with secondary antibodies (from Thermo-Fisher 
Scientific), Goat anti-Rabbit IgG, Alexa Fluor 488, A-11008 1:200 and Goat anti-Mouse IgG, 





Total RNA was collected by homogenizing tissues in Invitrogen Trizol reagent. RNA was DNaseI 
treated with NEB DNaseI and cleaned on Zymo Research RNA Clean & Concentrate 25 columns. 
NEB M-MULV reverse transcriptase was used to generate cDNA. Primer sequences were obtained 
from PrimerBank (Wang et al., 2011) and validated prior to use. Primer sequences are listed in 
Supplementary Table 1. An Applied Biosciences QuantStudio Flex 6 thermocycler was used for 
amplification. The delta-delta-Ct method was employed to establish quantity differences.  
 
2.2.3 RNA-Seq. 
Whole urogenital sinuses were dissected from male mouse embryos at embryonic day E16.5 and 
E18.5. Tissues were homogenized in Trizol and RNA was isolated. RNA was treated with NEB 
DNase I, then analyzed on a Bioanalyzer for quality. RNA-Seq libraries were prepared with KAPA 
Biosystems KAPA Stranded mRNA-Seq Kit for Illumina Platform (KR0960 - V2.14). Single-end 
reads were performed on Illumina Hi-Seq 2000 sequencers. Single stranded sequencing reads were 
processed with Tophat 2.1.0 (using Bowtie 2.1.0 and Samtools 0.1.19) with all Tophat options at 
default. Cufflinks 2.2.1 was used to determine differential expression. Results were filtered to 
consider only those genes with at least 1 FPKM in either the mutant or control samples for the 
final selection of differentially expressed genes.  Datasets reported in this study have been 





2.2.4 Mouse breeding. 
All mouse lines used were bred onto B6C3-F1 hybrid background because genetic background 
appears to influence Tbx18 phenotype severity (Bolt et al., 2014). Animal work described in this 
study was carried out in strict accordance with the recommendations in the Guide for the Care and 
Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the 
Institutional Animal Care and Use Committee of the University of Illinois (Animal Assurance 
Number: A3118-01; approved IACUC protocol number 15245) 
 
2.2.5 Generation of the Tbx18Flox allele. 
The conditional Tbx18 allele was generated by inserting LoxP sites flanking the second exon of 
the endogenous Tbx18 gene. In crosses with mice carrying the epibliastic Meox2-Cre knockin 
allele [B6.129S4-Meox2tm1(cre)Sor/J (Tallquist and Soriano, 2000); obtained from the Jackson 
Laboratory, Bar Harbor, ME] homozygous Tbx18 flox/flox mice displayed phenotypes identical to 
those previously published for global Tbx18-null mice, confirming the efficient ablation of Tbx18.  
 
2.2.6 CLARITY on UGS. 
UGS from the appropriate stage and genotype were dissected out and cleared in RIMS solution 
(15ml of 20mM phosphate buffer pH 7.5, 20g Histodenz, 250ul Sodium Azide 10% solution) 






2.3.1 Tbx18 is expressed in the early urogenital sinus mesenchyme. 
Previous reports of the Tbx18 expression pattern in the urogenital system have not included 
analysis of the urogenital sinus or prostate (Airik et al., 2006, Bohnenpoll et al., 2013). However, 
the prostate develops at the base of the bladder in near proximity to the ureter, and the obvious 
parallels between the development of these two structures prompted a careful re-evaluation.  
 
We set out to determine the quantity and location of native Tbx18 expression in prostate through 
the late stages of gestation and the postnatal days through puberty. We used tested whole mount 
expression of Tbx18 using a “knocked in” GFP allele Tbx18:GFP and to see Tbx18 lineages we 
used a endogenous Cre line Tbx18:Cre and a GFP reporter ZsGreen. High expression of Tbx18 
was seen in the anterior prostate and rhabdospincter at P1 which reduced considerably by P8 (Fig. 
2.1). Next, we used quantitative reverse transcript PCR (RT-qPCR) to detect Tbx18 mRNA in the 
UGS beginning at E14.5, before prostate development initiates, through gestation and the first few 
days after birth. Tbx18 mRNA was barely detectable at E14.5, rose dramatically by E16.5, and 
dropped slowly throughout the first week post-natal. Shortly after P3 and continuing over the first 
two weeks of postnatal development, Tbx18 mRNA levels dropped towards the limits of qPCR 
detection (Fig. 2.2A).  
 
To provide spatial resolution of TBX18 protein localization, we used immunohistochemistry 
(IHC) with a tested TBX18 antibody (Bolt et al., 2014) in sectioned E16.5 to P3 animals. At E16.5, 
TBX18 staining was observed primarily on the dorsal aspect of the UGS-M, proximal to the 
epithelium in regions from which the dorsal and anterior prostate buds will eventually emerge (Fig. 
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2.2B). At P0, TBX18 was also detected adjacent to the dorsal UGS-E with staining around the 
proximal regions of the epithelial prostate buds (Fig. 2.2D) and a few isolated cells ventral to the 
UGS-E. By P3, TBX18 was detected in clusters of cells in the UGS-M proximal to the prostate 
epithelial buds (Fig. 2.2F). Due to the known role of Tbx18 in smooth muscle formation, we also 
examined the relationship between TBX18 expression and smooth muscle formation by evaluating 
alpha-Smooth Muscle Actin (SMA) antibody staining on sections adjacent to those stained for 
TBX18. Consistent with previous reports of TBX18 and SMA expression, the expression of these 
two proteins were mostly spatially and temporally separated (Airik et al., 2010). SMA staining 
was frequently observed in cells in the vicinity of TBX18-positive cells, but the two proteins were 
largely detected in non-overlapping domains (Figs. 2.3C, 2.3E  and 2.3G). Together these analyses 
indicated that Tbx18 UGS expression is primarily limited to late gestation and early postnatal 
stages. The position of the TBX18+ cells adjacent to nascent prostate buds suggested they may 
contribute to the adult prostate stroma.  
 
We used a lineage-tracing system to identify the adult prostate regions and cell types to which 
TBX18+ embryonic cells contribute, crossing mice carrying a Cre recombinase knock-in to the 
Tbx18 locus (Cai et al., 2008) with the Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (mT/mG) reporter 
line. In these animals, only Cre-expressing cells and their descendants will express eGFP 
(Muzumdar et al., 2007). We observed GFP expression, indicating the presence of Tbx18-driven 
Cre activity, first at E16.5 in the UGS-M (not shown) and at P0 with the same patterns as that 
detected in IHC (Figs. 2.3H and 2.3I). In prostates of 5 week-old animals, we observed GFP 
expression in the periductal stromal smooth muscle layer of the anterior and the dorsolateral lobes 
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confirming that Tbx18-expressing cells contribute significantly to prostate stromal SMCs (Fig. 
2.3J and 2.3K). 
2.3.2 Subtle abnormalities in the nascent prostate of Tbx18 mutant mice. 
Tbx18 expression in the UGS during embryonic and postnatal stages suggested that Tbx18 might 
play a role in prostate development. However, most prostate development occurs postnatally 
precluding the use of Tbx18-null mutations to identify later prostate phenotypes. Since ureter 
expression and development are disrupted in 12Gso mice (Bolt et al., 2014), we reasoned that this 
hypomorphic allele might be associated with Tbx18 gene expression differences and phenotypes 
in the prostate as well.  
 
We first evaluated the effects of Tbx18 abrogation by comparing UGS morphology in Tbx18GFP/GFP 
null mutants, hypomorphic 12Gso/Tbx18LacZ (Bussen et al., 2004, Bolt et al., 2014) compound 
heterozygotes, and wild type littermates at two prenatal stages: E16.5, before the time that prostate 
budding begins, and E18.5, after the process has initiated. At both prenatal stages we observed no 
morphological differences between animals of the three genotypes (data not shown).  
 
However, at P0, we observed two subtle but consistent changes. We sectioned through the entire 
abdominal region including the developing prostate in multiple animals (n=7 of each genotype) 
and stained slides at regular intervals to compare morphology in a large sampling of sectioning 
planes. The differences between mutant and wild type prostates at this stage were subtle but 
consistently observed throughout the organs. First, in animals of both mutant genotypes, the apical 
surface of the urethral epithelium displayed increased convolutions and irregularities compared to 
wild type (Tbx18+/+) littermate controls (Figs. 2.3A, 2.3D and 2.3G). In the Tbx18-null animals, 
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we also noticed that epithelial cells displayed increased cell size and nuclear volume (arrows in 
Figs. 2.4C, 2.4F and 2.4I). In addition, the epithelium in both mutant genotypes was relatively 
thicker, with additional layers protruding into the lumen from the dorsal and ventral sides, than 
was observed in wild type littermate controls (Figs. 2.4 C, 2.4F and 2.4I). We quantified the 
differences by measuring the thickness of the urethral epithelium (luminal surface to basement 
membrane) at ten positions on both the dorsal and ventral aspect in wild type and Tbx18 mutants 
and confirmed that the ventral urethral epithelium was increased in Tbx18GFP/GFP mutants, while 
the dorsal epithelium thickness was increased in both mutants (Fig. 3J). We also observed that the 
characteristic pattern of higher UGS-M cell density around the forming prostate buds of wild type 
mice was absent in Tbx18GFP/GFP mutant animals and reduced in 12Gso/Tbx18LacZ compared to 
wild type litter mates (Figs. 2.4B, 2.4E and 2.4H).  
  
2.3.3 Loss of Tbx18 affects the structure and integrity of the anterior prostate lobe. 
Most of the prostate develops postnatally, with a significant amount of growth and differentiation 
during adolescent and pubertal stages up to five weeks after birth (Sugimura et al., 1986). We 
therefore reasoned that more striking morphological differences might be detected in mutant 
animals at 5 weeks. Although 12Gso/Tbx18LacZ compound heterozygotes only occasionally survive 
to adulthood, we did observe a striking phenotype in two 5-week-old males we examined (Fig. 
2.4). Subtle abnormalities were detected in the dorsolateral lobes, but the most striking phenotypes 
were limited to the anterior prostate.  
 
When the anterior prostates of these mutants were sectioned along the axis proximal-distal to the 
urethra, we observed a very similar phenotype in both animals. Specifically, the regions of the 
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anterior ducts located distal of the urethra displayed overtly normal structure, including organized 
epithelial folds encased by thin layer of condensed smooth muscle stromal cells (Figs. 2.4A and 
2.4B). We could discern no obvious difference between these distal regions of mutant anterior 
prostates and those of wild type littermate controls (Figs. 2.4C and 2.4D). However, in the more 
proximal regions of the same ducts, the mutant anterior prostates were significantly different from 
those in wild type animals in two respects. First, we noted a marked increase in the thickness of 
the stromal smooth muscle layer, containing cells that were significantly increased overall in size 
and misshapen, compared to age-matched wild type prostates (Figs. 2.4A, 2.4E, 2.4C and 2.4D). 
Second, we observed that epithelium directly adjacent to the disorganized stroma in the mutants 
lacked the typical well-organized morphology and cell layering seen in comparable wild type 
sections. Rather, cells in the epithelial compartments of these proximal regions were disorganized 
and appeared to be loosely associated in the mutant mice (arrowhead in Figs. 2.4E and 2.4F).  
 
To quantify cell number and cell size we measured the stromal thickness (the distance from the 
epithelial basement membrane to the distal stromal periphery) at twenty positions around the 
anterior prostate lobes and counted the number of nuclei along the same linear path of 
measurement (Fig. 2.4G). We found that the mean stromal width was significantly larger in 
12Gso/Tbx18LacZ mutants than in wild type littermates on average: 45μm  +/- 6.9μm in wild type, 
versus 68.2 +/- 7.3μm and 71.0 +/- 11.0μm for 12Gso/Tbx18LacZ mutant prostates respectively. By 
measuring the ratio of the number of nuclei per stromal width, we observed a decrease in the 
number of nuclei per width in the prostate stroma of 12Gso/Tbx18LacZ mutants (Fig. 3G), 
supporting a hypertrophy model. Thus, it appears the abnormal stromal thickness is due to cells 
occupying the periductal space normally reserved for stromal SMC were enlarged and lacked the 
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condensed, parallel organization observed in wild type mice. In these morphological 
characteristics, the abnormal stromal cells in Tbx18 mutant prostates resemble myofibroblasts, 
which are frequently associated with prostate pathologies (Tuxhorn et al., 2002, Shaw et al., 2008).  
 
2.3.4 Conditional ablation of Tbx18 in the prostate 
The survival of 12Gso/Tbx18LacZ animals to adulthood was sufficiently rare to impede efficient 
further investigation. To overcome this problem, we obtained a conditional allele of Tbx18 
(Tbx18flox). To remove Tbx18 function only in the developing prostate, we required a tissue specific 
Cre that would not interfere with Tbx18 function in other tissues that have previously been 
associated with loss-of-function lethality. We therefore chose to abrogate Tbx18 in the prostate 
utilizing a well-tested transgenic mouse line expressing Cre-recombinase from a transgenic rat 
Probasin gene promoter (PB-Cre4) (Wu et al., 2001b).  
 
PB-Cre4 is expressed at highest levels in the postnatal mouse prostate epithelium and is most 
commonly used to study epithelial development. However, this transgene is also expressed within 
the mesenchyme adjacent to the dorsal and anterior lobes, with activity in the mesenchyme 
reported as early as P1 (Wu et al., 2011, Zhang, 2000). We confirmed the mesenchymal expression 
of PB-Cre4 and the overlap between Cre and TBX18 expression in prostate mesenchyme using 
mT/mG reporter strain co-stained with TBX18 antibody. In PB-Cre4+; mT/mG+ mice, we observed 
Cre activity in UGS-M cells surrounding the emerging prostate buds, as early as P0 (Fig. 2.5). In 
sections co-stained with the TBX18 antibody we confirmed that Tbx18 and PB-Cre4 are co-
expressed in a subset of the same stromal cells around the emerging prostate buds at this stage, 
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with TBX18 protein (stained with far red and shown in pink) localized clearly in the nucleus of 
cells that were also expressing membrane-targeted GFP (green in Figs. 4A-C). 
 
To evaluate the conditional loss of Tbx18 in these cells, we produced PB-Cre4+, Tbx18flox/flox 
animals and collected prostates at 5.5-6.5 weeks of age (n=6 animals). The phenotype we observed 
in these animals was highly consistent with that of the 12Gso/Tbx18LacZ phenotype, characterized 
by patches of tissue with a thickened prostate stroma surrounding a highly disorganized 
epithelium. As in 12Gso/Tbx18LacZ prostates, this phenotype was focused primarily in the anterior 
prostate lobes and in regions proximal to the urethra, with obviously abnormal ducts adjoined to 
normally structured acini in the same tissue sections (Fig. 2.5D-F). Therefore, the inheritance of 
the 12Gso/Tbx18LacZ genotype and deletion of Tbx18 in PB-Cre4-expressing cells yield very 
similar effects on prostate development.  
 
2.3.5 Immunohistochemical markers confirm the presence of myofibroblasts and loss of 
epithelial cell identity in mutant prostates  
To further characterize these abnormal prostate phenotypes, we stained mutant and control prostate 
sections for expression of diagnostic molecular markers. We used slides directly adjacent to those 
highlighted in Figures 3 and 4 for immunohistochemical staining, comparing staining patterns 
from both types of Tbx18 mutants to wild type age-matched controls, with very similar results 
(Fig. 2.6). First, we asked whether epithelial cell-type balance was being maintained by examining 
mutant and wild type sections with cytokeratin markers of basal or luminal epithelial cell identity 
(CK5 and CK8, respectively) (Niu et al., 2011); these slides were co-stained with the SMA 
antibody to delineate stromal and epithelial layers clearly. Next, we examined prostate sections 
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adjacent to those stained with CK markers, after co-staining with Vimentin (VIM) and SMA. 
These proteins separately mark fibroblasts and smooth muscle cells, respectively, but when 
expressed together are characteristic of the myofibroblastic phenotype (Tuxhorn et al., 2002).  
 
Tbx18-mutant anterior lobes contained stromal smooth muscle cells and epithelium at the distal 
portions of the lobes that matched the organization and staining patterns of wild type lobes at 
equivalent positions (Figs. 5A-C). In these normally structured regions, a layer of flattened, SMA-
positive cells surrounded an organized epithelium. In the epithelium, a basal layer marked by CK5, 
and a luminal layer of CK8+ cells was apparent (shown in Figs. 2.6D and 2.6E). In contrast, cells 
within the epithelial compartments of the abnormally structured proximal ductal regions in both 
12Gso/Tbx18LacZ (Figs. 2.6G and 2.6H) and PB-CRE4+;Tbx18flox/flox mutants (Figs. 2.6J and 2.6K) 
displayed significantly reduced expression of both epithelial markers.  
 
We also found that the distribution of SMA and VIM-positive cells was very similar in the 
normally structured distal regions of mutant anterior prostates and the prostates of wild type 
littermates. Specifically, VIM+ cells were distributed around the outside of the normally structured 
ducts in mutant mice, and VIM staining did not co-occur with SMA (Fig. 2.6F). In contrast, in the 
disorganized proximal regions of the mutant anterior prostates we observed clusters of stromal 
cells co-staining with VIM and SMA (arrows in Figs. 2.6I and 2.6L). This pattern was observed 
in multiple sections across proximal regions of the anterior prostate in both types of Tbx18 mutants 
(not shown). In addition, we observed unusually large numbers of cells marked by VIM but not 
with SMA, in the periductal space surrounding the myofibroblastic cells and the abnormal 
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epithelium in the mutant anterior prostate lobes. This staining pattern suggests an abnormal 
increase in numbers and organization of stromal fibroblasts in the mutant prostates. 
 
2.3.6 Significant gene expression differences presage Tbx18 mutant prostate pathology. 
The subtle UGS phenotype observed in newborn animals (Fig. 2.4), in conjunction with the fact 
that Tbx18 transcription was first detected at significant levels in UGS at E16.5 (Fig. 2.2), indicated 
that the earliest detectable molecular changes associated with Tbx18 deficiency would be 
discovered between E16.5 and P0. This time period is also critical for the formation of the first 
prostate buds and marks the beginning of mesenchymal condensation around the nascent prostate 
buds (Lee et al., 1990, Sugimura et al., 1986). To determine potential gene expression changes in 
Tbx18-null UGS, we collected whole UGS from E16.5 and E18.5 Tbx18GFP/GFP mutant male 
embryos and littermate wild type controls. For each stage, we isolated RNA and performed RNA-
Seq, comparing gene expression in mRNA from pooled tissues from each genotype at each stage. 
Gene expression analysis identified 324 differentially expressed genes (DEGs) at E16.5 and 6101 
DEGs at E18.5 with an absolute fold change greater than or equal to 2.0; including genes with 
absolute fold change above 1.5 at the earlier stage identified a total of 694, many of which were 
further dysregulated at the later stage (Supplemental Table 1). To determine which major 
functional categories were differentially expressed at these two stages, we performed Gene 
Ontology (GO) analysis on the DEG sets using the DAVID functional analysis program (Table 
2.1) (Huang et al., 2009).  
 
At E16.5 nearly every enriched Functional Category was related to myogenesis and muscle 
structure. The most highly enriched of these categories included genes that encode structural 
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components of myofibrils including Smooth muscle actins (Acta2, Actg2), Calponin 1 (Cnn1), 
smooth muscle Myosin heavy chain 11 (Myh11), and Transgelin (Tagln) all of which were 
significantly down-regulated in mutants at E16.5. Genes encoding protease inhibitors (particularly 
the Stephin family of Cathepsin inhibitors; Stfa1, Stfa2, Stfa2l1, Stfa3), extracellular components 
(Col10a1, Gdf15, Fgg, and Fgb) and genes involved in defense response, the complement cascade, 
and inflammatory response (e.g. S100a8, S100a9, C3, Cd52, Masp2) were significantly up-
regulated at this early stage (Table 1).  
 
Despite the fact that major morphological differences were not observed in mutant UGS until P0, 
RNA-seq analysis of E18.5 mutant UGS detected a massive difference in gene expression between 
mutant and wild type mice with highly significant functional enrichments. Most notably, down-
regulated DEGs were enriched for transcription factors including the key muscle differentiation 
factors including Mef2a, Mef2c, and Mef2d. At this stage, we also observed significant differential 
expression of TF genes including Sox9, Hoxd13, Pten and Trp63, all genes with important roles in 
prostate development and pathologies (Wu et al., 2001a, Peng and Joyner, 2015, Kurita et al., 
2004). Genes regulating apoptosis and the proliferation of mesenchymal and epithelial cells were 
also down-regulated (Table 2.1); here we should note that because of its action in other tissues, 
Tbx18 itself is annotated in both the apoptosis and cell proliferation categories, as are down-
regulated DEGs Shh, Trp63 and Fgfr2. 
 
Tellingly, components of the extracellular matrix including eight Collagen, nine Matrix 
metalloprotease, as well as Wnt genes were also significantly up-regulated (Table 2.1), all of which 
have known roles in myofibroblast formation. DEGs associated with regulation of smooth muscle 
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proliferation (including Bmp4, Notch4) were also enriched in the up-regulated genes. We also 
observed at this stage a massive up-regulation of genes directly involved in the formation of the 
ribosomes and mitochondrial components which are also up-regulated in myofibroblasts 
(Negmadjanov et al., 2015). To confirm the results of the RNA-Seq study, we validated several 
genes at both developmental time points. Using RT-qPCR on RNA from individual UGS samples, 
we found that the results were highly consistent with the differential expression values from the 
pooled tissues used in sequencing (Fig. 2.7). 
 
To assign particular genes and functions to mesenchymal or epithelial compartments, we cross-
referenced our DEG sets with genes enriched in dissected UGS-M or UGS-E in a published 
microarray study (overlaps marked as M or E in Supplemental Table 1) (Blum et al., 2010). 
Through this intersection, E16.5 functions related to regulation of myogenesis, muscle structural 
proteins, and inflammation were assigned to UGS-M; at E18.5 functions related to mitosis, 
mesenchymal cell development, and negative regulators of apoptosis were significantly down-
regulated, while the C1Q complement system, regulation of cell shape, and Hedgehog signaling 
were up-regulated in the mesenchymal compartment. At the later stage, functions related to 
epithelial cell development, apoptosis, apical junctions, and prostate gland development were 
assigned to the UGS-E, while up-regulated functions related to cell adhesion and cell migration, 
NADP metabolism, secretion, and Wnt superfamily members were also associated with in the 






2.4 DISCUSSION  
This study provides the first evidence that Tbx18 is required for normal differentiation of the 
prostatic stroma and that it indirectly influences the organization, proliferative control, and cellular 
identity of prostate epithelium. Using three different mutant genotypes, we show that Tbx18 loss-
of-function in the UGS during late embryogenesis and early postnatal life results in grossly 
disorganized stromal and epithelial layers of the anterior prostate in young adults, with many of 
the periductal stromal cells displaying a myofibroblastic phenotype.  
 
Analysis of gene expression in mutant embryos revealed a cohort of functionally related, 
differentially expressed genes that may presage this later pathology. Most notably, genes involved 
in muscle development were already significantly down-regulated, while genes associated with 
extracellular matrix remodeling and inflammatory response were up-regulated in mutants as early 
as E16.5. These up-regulated functions are the same as those known to be associated with the 
appearance of myofibroblasts and epithelial dysplasia in adults (Tuxhorn et al., 2002), indicating 
a predisposition for the formation of later pathologies at this very early age. Since E16.5 is also 
the time when Tbx18 is first robustly detected in wild type prostates, the data suggest an essential 
role for Tbx18 in the regulatory hierarchy controlling expression of those genes. 
 
By P0, we observed the first signs of morphological differences in developing mutant prostates 
including decreased density of UGS-M cells surrounding the prostate buds, possibly linked to 
proliferative failure of Tbx18-deficient mesenchymal cells as observed for ureter development 
(Trowe et al., 2008). In addition to these stromal abnormalities, the epithelium displayed increased 
thickness and subtle loss of organization in Tbx18 mutants at this stage. However, these minor 
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morphological changes belie the significant molecular and genetic changes that have already taken 
place within these cells.  
 
Prominent among down-regulated DEGs in E18.5 embryos were transcription factors and 
signaling pathways with important roles in mediating cell-type specific differentiation in prostate. 
For example Hoxd13 loss-of-function mutations result in reduced anterior prostate size with 
increased mesenchymal thickness (Podlasek et al., 1997). Foxa1 directly promotes cell growth in 
the prostate via an AR-dependent pathway and indirectly regulates other genes that are essential to 
prostate development, including Shh and Bmp4 (Jin et al., 2013) which were also dysregulated in 
Tbx18GFP/GFP UGS at E18.5. Sox9, which interacts with Tbx18 in ureter development (Airik et al., 
2010), was also significantly dysregulated at E18.5; this gene is already well established for its 
critical role in prostate development. For example, inactivation of Sox9 before Androgen Receptor 
activation results in complete agenesis of the prostate (Huang et al., 2012, Thomsen et al., 2008); 
at later developmental stages, Sox9 is required to promote basal epithelial proliferation and is 
regulated by Wnt signaling through β-catenin (Wang et al., 2007, Wang et al., 2008). Interestingly, 
many of these same developmental regulators are dysregulated in prostate cancer (Schweizer et 
al., 2008, Huang et al., 2012, Jin et al., 2013, Wang et al., 2008), and their early mis-expression 
may be linked to the cellular changes we detected in young adult mutant mice.   Since these genes 
are mostly epithelial and (as far as we can discern) Tbx18 is never expressed in prostate epithelial 
cells, the effects of Tbx18 on the expression of Hoxd13, Shh, Bmp4, and Sox9 must be indirect, 




Although the phenotype of newborn mutant animals does not reflect the massive shift in the 
prostate gene expression that is already evident at E18.5, the failure of developmental and 
signaling pathways and the signature of inflammation are manifested clearly in 5 week-old mice. 
In contrast to the ureter, where the epithelium is reduced in thickness and cell numbers as well as 
organization in Tbx18-/- mice (Airik et al., 2006, Nie et al., 2010), the cells that populate the adult 
prostate epithelium are not obviously reduced in number and instead, the numbers of cells in the 
epithelial compartment appear to have increased. These differences may stem from the distinct 
developmental origins of the epithelial layers and the paracrine factors they produce, as ureter 
epithelium is of mesodermal origin, and UGS-E is endodermal.  
 
However, these differences in epithelial phenotype may also reflect different fates of Tbx18-
deficient stroma in ureter and prostate. In particular, whereas Tbx18-deficient cells in ureter 
undergo apoptosis and are replaced by a thin layer of fibroblasts (Airik et al., 2006), in prostate 
these cells appear to be replaced by a myofibroblasts (MFBs), which support the proliferation of 
epithelial cells. The origins of these MFBs and the role of Tbx18 in their formation are still unclear 
and will require an in-depth developmental study. MFBs are most commonly thought to 
differentiate from fibroblasts, and it is possible that Tbx18-prospective cells are first replaced by 
fibroblasts that further differentiate to MFBs in the prostate environment. We did detect an increase 
of Vimentin-positive cells in the lumen of mutant glands, and these might serve as a reservoir for 
MFBs.  
 
However, other possibilities should be considered. For example, Vimentin is expressed widely 
throughout the prostate stroma during prenatal development, and VIM+SMA+ MFBs are also 
42 
 
present during these stages, presumably reflecting an intermediate differentiation state (Hayward 
et al., 1996b, Bierhoff et al., 1997). Therefore, one possibility is that in the absence of Tbx18, 
mesenchymal cells destined for the SMC fate may simply fail to differentiate beyond this 
transitional stage. Alternatively, MFBs can also arise directly from mesenchymal stem cells that 
reside in human prostate, a process that is inhibited by the TGFB1-regulated TF, RUNX1 (Kim et 
al., 2014). Runx1 was significantly down-regulated in Tbx18-mutant UGS at E18.5, raising the 
possibility that Tbx18-deficient mesenchymal precursors are redirected in mutant prostate anterior 
lobes to differentiate into MFBs. Using the Tbx18flox allele in combination with PB-Cre4 and other 
mesenchymally-expressed Cre alleles, these possibilities can now be tested. 
 
Whatever their origins, the appearance of MFBs in the Tbx18 mutant stroma provides a potentially 
novel link between the developmental activities of this T-box factor and predisposition to adult 
prostate disease. MFBs are associated with multiple types of human prostate pathologies, including 
prostate cancer as well as benign prostate hypoplasia, and prostatic fibrosis (Schauer and Rowley, 
2011, Gharaee-Kermani et al., 2012). Most of the factors that have been linked to MFB 
differentiation are expressed in adult prostate, either normally or in response to injury, infection, 
or other inflammatory events. However, as far as we can discern from RT-qPCR, IHC, and lineage 
tracing studies, Tbx18 is expressed only transiently during early development and is not reactivated 
in the prostates of either healthy or mutant adults. These data suggest that a deficiency of Tbx18 
during a limited period of perinatal development is sufficient to predispose animals to frank 
prostate disease later in life. We speculate that the loss of Tbx18 sets the stage for later prostate 
dysfunction through loss of a functional SMC stroma, but also due to the early creation of an 




Finally, from these data it remains unclear which stromal factors are key to the abnormalities in 
epithelial proliferation, differentiation and organization we observed since a large number of 
pathways predicted to influence these processes were dysregulated together in Tbx18 mutant mice. 
Nevertheless, it is clear from our observation of these phenotypes in several different Tbx18 
genotypes that these factors are under the control, either directly or downstream and indirectly, of 
TBX18. Future studies will focus on pinpointing the mechanisms of Tbx18 activities in prostate 
development and examine in depth the long-term effects of Tbx18 insufficiency during the earliest 





2.5 TABLE AND FIGURES 
 
       
 Enriched functional Categories1 





















Muscle organ development 
Muscle system process 
Muscle cell differentiation 
Sarcoplasmic reticulum 
Cytoskeletal protein binding 
Myosin complex 





Regulation of transcription 
Zinc finger/zinc ion binding 
Chromosome organization 
mRNA processing 
Microtubule organizing center 
Cell cycle 
Ribonucleoprotein complex 
Cellular response to stress 
Programmed cell death 
Establishment of protein localization 
Regulation of mesenchymal cell 
proliferation 
Regulation of epithelial cell proliferation 
Prostate gland growth 
Skeletal system development 
Serine threonine kinase activity 













Peptidase inhibitor activity 
Extracellular region 
Defense response to bacterium 
Complement and coagulation 
cascades 
Nucleosome assembly 





Proteinaceous extracellular matrix 




Regulation of smooth muscle proliferation 
Regulation of Ras GTPase activity 
 
Table 2.1 Functional categories enriched in RNA-seq comparison of E16.5 and E18.5 Tbx18 







Figure 2.1 Whole-mount expression of Tbx18 in prostate. Using CLARITY (Chung and 
Deisseroth, 2013), 3D imaging of the developing UGS was performed to visualize expression of 
Tbx18. Using a GFP knock-in of Tbx18 (Tbx18 
Gfp/+
) high expression of Tbx18 was seen in the 
anterior prostate and rhabdospincter at P1 (A). By P8 expression of Tbx18 is greatly reduced (C), 
after this time-point it cannot be detected. Lineages of Tbx18 can be visualized by using a Cre 
knock-in (Tbx18 
cre/+
) and a reporter allele that expresses GFP on recombination (Rosa 
mtmg/+
). The 
lineages are strong in the rhabdospincter and anterior prostate (C). Abbreviations: R- 





Figure 2.2 Tbx18 expression in the urogenital sinus mesenchyme. (A) Quantitative reverse 
transcription PCR detects Tbx18 mRNA as early as E14.5, with expression peaking around 
embryonic day 16.5 (for each stage n ≥ 4). (B, D, F) TBX18 immunohistochemistry shows TBX18 
is expressed in the dorsal aspect of the UGS in the region of the forming anterior prostate buds at 
E16.5 (B), P0 (D), and P3 (F). (C, E, G) Smooth Muscle Actin IHCs on sections adjacent to TBX18 
stains showing the proximity of these two expression domains. The expression of these two genes 
rarely overlaps; TBX18 is only detected in a subset of cells in the same region as SMA. (H-K) 
Lineage tracing analysis of Tbx18 expressing cells using the Gt(ROSA)26Sortm4(ACTB-tdTomato,-
EGFP)Luo/J reporter. Green cells express or are descended from Tbx18 expressing cells (in the images 
presented here, the Tomato signal was excluded for clarity). (H-I) P0. (J-K) P35 sections show 
Tbx18 descendants primarily occupy the anterior prostate stroma (J), and dorsal prostate stroma 







Figure 2.3 Tbx18 LOF phenotype in P0 UGS.  
(A-I) H&E stains of P0 urogenital sinuses. (A-C) Wild type histology shows high cell density in 
the mesenchyme surrounding the epithelial prostate buds (A, B), and urethral epithlium is 
composed of 4-6 cell layers with a smooth apical surface (C). (D-F) 12Gso/Tbx18LacZ compound 
heterozygotes present an intermediate phenotype in the UGS mesenchyme and the urethral 
epithelium. (G-I) Tbx18GFP/GFP mutants have very low mesenchymal cell density surrounding 
epithelial prostate buds. The urethral epithelium in these mutants is increased in thickness with 
larger cell volumes (compare arrows in C, F, and I). (J) Measurements of the epithelial thickness 
in the urethral epithelium. The epithelium on the dorsal side is significantly increased in thickness 






Figure 2.4 Tbx18 LOF in 12Gso/Tbx18LacZ mutants leads to prostate abnormalities in adults. 
The anterior prostates of five-week-old 12Gso/Tbx18LacZ mutants include stromal hypertrophy and 
epithelial disorganization, as revealed by Hematoxylin and Eosin (H&E) stains. Sectioned anterior 
prostates of 12Gso/Tbx18LacZ mutants (panel A, with areas highlighted in black, blue, and white 
boxes shown at high resolution in B, E, F respectively) include distal regions with relatively normal 
morphology (B) indistinguishable from that of wild type littermates (C, D). However, the same 
sections of mutant prostates show significant stromal hypertrophy (E) and epithelial 
disorganization and lack a clear boundary between stromal and epithelial compartments (F) in 
regions proximal to the urethra. (G) Measurement of stromal thickness and numbers of nuclei 
within the stromal regions confirm that both measurements are significantly different in mutant 
proximal anterior prostates than in wild type littermate controls. S is stroma; E is epithelium. Scale 





Figure 2.5 Conditional ablation of Tbx18 in the prostate.  
(A) The PB-Cre4 transgene is active at P0 in the prostatic mesenchyme as shown by the mT/mG 
reporter line, and (B, C) cells with Cre expression co-stain with TBX18 around the anterior buds. 
(D-F) PB-Cre+; Tbx18Flox/Flox animals display similar pathology to the 12Gso/Tbx18Lacz animal at  
P35, with (E) urethra-proximal regions of stromal hypertrophy and epithelial disorganization and 
(F) distal regions of the same ducts displaying normal pathology. Scale bars correspond to 100μm 
in figures (A, D-F) and 50μm in figure (B,C). AP is anterior prostate mesenchyme. DLP is 





Figure 2.6 Immunohistochemical analysis with stromal and epithelial markers. 
We used immunohistochemistry to examine the distribution of stromal and epithelial markers in 
sections of 5 week-old (A-C) wild-type, (D-I) 12Gso/Tbx18LacZ, and (J-L) PB-Cre4+ ; Tbx18flox/flox 
anterior prostates. IHC was carried out on slides adjacent to those imaged in Figures 2.4, 2.5 and 
include the same regions of the tissue. (A) Luminal epithelial cells stained with Cytokeratin 8 
(CK8, green) form a continuous layer on the apical surface of the epithelial compartment in wild 
type prostate and (D) in distal ductal regions with normal pathology in the 12Gso/Tbx18LacZ 
compound heterozygotes. (B, E) Basal epithelial cells stained with Cytokeratin 5 (CK5, green) 
also stain similarly in the wild type and distal regions of the mutant ducts, forming a discontinuous 
layer between the apical and basement membrane. (G, H, J, K) In contrast, CK8 and CK5 staining 
is significantly reduced in the epithelial compartments of the proximal anterior prostate regions in 
both 12Gso/Tbx18LacZ (G, H) and PB-Cre4+ ; Tbx18flox/flox mice (J, K). SMA (red) was co-stained 
with the Cytokeratin markers to define the smooth muscle layer of the stroma in each section. (C,  
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Fig. 2.6 cont. 
F) Smooth muscle cells, identified with SMA (red), and fibroblasts, stained with the VIM antibody 
(green) form apposed but separate layers around the epithelial compartments in wild type animals 
and in distal regions of normal histology in the anterior prostate of 12Gso/Tbx18LacZ mice. (I, L) 
However, in both types of Tbx18 mutants we found cells positive for both the VIM and SMA 
markers (arrow in Fig. I, L), indicative of myofibroblasts. In addition, compared to wild type 
littermates (C), the mutant anterior lobes contained larger numbers of VIM+ cells (green; 






Figure 2.7 Validation of differentially expressed genes. In the RNA-Seq experiment we 
analyzed pools of tissues from three individuals for each genotype and each stage. To validate that 
the pooled averages reflect individual samples we performed RT-qPCR on individual samples. 
The Fold Changes observed in RNA-Seq (no error bars) are presented next to the FCs obtained 






AN EXTENDED REGULATORY LANDSCAPE DRIVES TBX18 




The Tbx18 gene encodes a deeply conserved T-box transcription factor (TF) that is expressed 
dynamically throughout development, with central roles in the differentiation of mesoderm-
derived cell types in a wide variety of embryonic tissues (Naiche et al., 2005, Papaioannou, 2014). 
As a testament to this gen2e’s essential functions, Tbx18 null mutant (Tbx18-/-) mice die perinatally, 
with abnormalities of the axial skeleton, hydroureter and hydronephrosis as the most obvious 
visible phenotypes (Bussen et al., 2004, Airik et al., 2006). However, mutant animals also display 
defects in the heart, kidneys, and inner ear, trabecular bone and other tissues (Cai et al., 2008, 
Bohnenpoll et al., 2013, Wu et al., 2013).  
 
We previously described a mouse reciprocal translocation, called 12Gso, which breaks 
approximately 70 kb downstream of the Tbx18 gene and reduces its function in a tissue- and 
developmental time-specific manner, creating a hypomorphic loss-of-function (LOF) allele (Bolt 
et al., 2014). The translocation acts by disrupting a conserved “gene desert” region surrounding 
Tbx18 and separating the Tbx18 promoter from downstream enhancers including an element called 
                                                 
2 This chapter appeared in the journal Developmental Biology in February 2019 titled the same 
as here, with PMID:30594504. 
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ECR1, which drives the continued expression of Tbx18 expression during later stages of ureter 
development. These data indicated that the Tbx18 gene desert houses a complex regulatory 
landscape extending far from the gene’s promoter. One previous study showed that a Tbx18-
containing 209 kb bacterial artificial chromosome (BAC) transgene could recapitulate most, but 
not all, of the gene’s pattern of developmental expression (Wang et al., 2009). However, the full 
extent and structure of the Tbx18 regulatory domain has not been elucidated in any tissue. 
 
Unlike Tbx18 full knockout alleles, 12Gso mutant animals can sometimes survive to adulthood, 
permitting us to examine Tbx18 LOF phenotypes in tissues that develop postnatally. Using 12Gso 
together with a LoxP-flanked (floxed) conditional Tbx18 allele we recently showed that Tbx18 
deficiency is associated with significant abnormalities in urethra-proximal regions of the anterior 
prostate lobe (Bolt et al., 2016). These abnormalities include the failed development of stromal 
smooth muscle cells and the appearance of inflammatory myofibroblasts, accompanied by a 
massive disorganization of the adjacent epithelium. We further showed that Tbx18 is expressed 
transiently in the caudal urogenital sinus (UGS), the embryonic structure from which the prostate 
develops, during a brief period peaking at embryonic day 18.5 (E18.5), just before the time of 
birth. Since 12Gso mutants display the prostate phenotype, we reasoned that enhancers essential 
to UGS expression during this critical perinatal period would be found downstream of the gene, 
and beyond the boundaries of the 12Gso translocation (Bolt et al., 2016).  
 
With the goal of mapping long-distance enhancers that interact with the Tbx18 promoter during 
prostate development, we carried out circular chromosome conformation capture (4C) and 
transposase-based mapping of open chromatin domains (ATAC-seq) in chromatin isolated from 
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E18.5 UGS tissue. The data reveal an extended landscape of promoter-contacting regions 
throughout a 1.5 - 2 million base pair (Mbp) domain surrounding the Tbx18 gene; this domain is 
roughly consistent with a region defined as the primary Tbx18 topologically associating domain 
(TAD) (Dixon et al., 2012). We combined these chromatin profiles with Cre-Lox-based lineage-
tracing studies to assign elements controlling Tbx18 expression in precursor cells with specific 
adult fates to subdomains within the TAD. Together, these data point to the locations of long-
distance enhancers, including the previously identified element ECR1, that regulate Tbx18 in a 
surprisingly large array of precursor cell types at a key stage in urogenital tract development.  
 
3.2 MATERIALS AND METHODS 
3.2.1 Mice and Lineage Tracing 
B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J (ZsG) reporter mice (Madisen et al., 2010), Tbx18:Cre 
(Cai et al., 2008) knock-in allele, B6.Cg-Tg(Tbx18-iCre)3Fech/J (Tbx18:BAC-iCre) transgenic 
mice (Wang et al., 2009) and ECR1-Lacz transgenic animals (Bolt et al., 2014) were all maintained 
by crossing heterozygous Cre-expressing animals to C3H/HeJ x C57BL/6J hybrid mice. All 
animal care and procedures in this study were carried out under strict adherence to the Guide for 
the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was 
approved by IACUC with protocol #15245 at the University of Illinois. The Cre lineages were 
studied by breeding male Tbx18:Cre/+ heterozygous and Tbx18:Bac-iCre animals with ZsG/ZsG 
homozygous females. For timed pregnancies vaginal plugs were checked in the morning after 
mating and noon was taken as E0.5. Genomic DNA was prepared from tail snips and used for 




3.2.2 Lineage Tracing and Immunohistochemistry 
Tissues were dissected at the appropriate age in cold phosphate-buffered saline (PBS) and fixed in 
4% paraformaldehyde (PFA) overnight at 4oC. Tissues were dehydrated and fixed in paraffin wax 
and then cut into 4-6um sections. For lineage tracing the green fluorescence (ZsGreen) was 
visualized directly. For immunohistochemistry, the sections were incubated overnight at 4ºC with 
the following antibodies MHC (DSHB, MF20, 1:50), NeuN (Millipore, ABN91, 1:200), Serotonin 
(Novus, 5HT-H209, 1:100). Following washes, the secondary antibodies Donkey anti mouse IgG 
594 (Invitrogen, R37115, 1:200) and Goat anti Chicken IgG 594 (Invitrogen, A-11042, 1:200) 
were applied as appropriate at room temperature for 1 hour. After washes, counterstaining with 
Hoescht 33342 (Invitrogen, H3570) and cover-slipping, the sections were imaged in the 
Hamamatsu Nanozoomer and Carl Zeiss confocal microscope LSM710.   
 
3.2.3 LacZ Staining  
For whole-mount LacZ stains the fresh tissue samples were washed and fixed in ice cold 4% PFA 
and 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-Gal; Invitrogen, 15520034) staining 
was applied as per the protocol outlined in (Loughna and Henderson, 2007).  For thin section 
staining, the lower abdomen was isolated, fixed in 4% PFA and frozen in OCT (Tissue-Tek, 4583) 
media. 10um sections were cut and then X-gal was applied, also as outlined by (Loughna and 
Henderson, 2007). Nuclear Fast Red (Vector Laboratories, H-3403) was applied for 






3.2.4 Chromatin Conformation Capture (4C) 
Chromatin conformation capture was performed essentially as described in (Gheldof et al., 2012) 
with these modifications. Each individual biological replicate was produced from five male E18.5 
urogenital sinuses dissected from CBA x C57BL/6 F1 embryos. Tissues were disaggregated by 
treatment with collagenase then fixed with 1% PFA for 10 minutes at room temperature. 
Approximately five million cells were used for each replicate. Chromatin was digested with three 
additions of 400U DpnII (NEB cat# R0543), followed by ligation, and a second digest with 400U 
HindIII (NEB cat# R0104). Independent chromosomal libraries from biological replicates were 
amplified with viewpoint primers (Supplemental Table 2). The forward and reverse primers map 
to the genomic interval chr9:87626944-87627578 on Mm9. Samples were sequenced on an 
Illumina HiSeq 2500 producing 30 million reads per sample. Mapping and the computational 
identification of peaks were performed on HTSstation (David et al., 2014, Noordermeer et al., 
2011). The 4C-seq reads are quantified and normalized by dividing each fragment score by the 
mean number of fragment scores that are located within a 1Mbp region upstream and downstream 
of the viewpoint. These profiles were then corrected by the HTSstation algorithm which adjusts 
for non-specific interactions as a function of linear distance on the DNA strand. The profiles were 
then smoothed on a sliding window of eleven restriction fragments. 
 
3.2.5 ATAC-seq 
ATAC-seq libraries were produced using a pool of 5 male urogenital sinuses that were treated with 
collagenase to disaggregate into single-cells. Cells were counted and 50000 individual cells (96% 
viability) were treated as described in (Buenrostro et al., 2015). We sequenced the ATAC library 
in HiSeq 2500 in two batches and obtained 55.4M and 20.6M single end reads. We trimmed the 
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reads to remove the Nextera transposase sequences at the ends using Trimmomatic  (Bolger et al., 
2014). We aligned the reads using Bowtie2 with default parameters (Langmead and Salzberg, 
2012) to mm9 with a 51% overall alignment rate. We called peaks using Homer (Heinz et al., 
2010) using default parameters and generated wiggle files to view on the UCSC browser (Kent et 
al., 2002). To identify related human regions, we performed a liftOver of these peaks to hg19 in 
the UCSC browser platform. We cross-referenced the human liftOver coordinates with coordinates 
of peaks from the Encode DNase1 Hypersensitive Sites (DHS) track (Thurman et al., 2012, John 
et al., 2011). Additionally, we used Homer to correlate the mouse ATAC-seq peaks to nearest 
promoter regions genome-wide and cross-referenced these peak-associated genes to UGS 




3.3.1 Tbx18 Promoter Contacts are Distributed Throughout a 1.5 Mb Topologically 
Associating Domain 
To identify regulatory elements contacting the Tbx18 promoter in the E18.5 male caudal UGS, we 
carried out circularized chromatin conformation capture (4C) experiments using hight throughput 
sequencing near the Tbx18 promoter as the “viewpoint” (see Methods). The experiments were 
carried out in duplicate on separate pools of tissue and both libraries were sequenced to collect a 
total of more than 30 million sequence reads. Reads were analyzed using the HTStation software 
(David et al., 2014) to reveal broad peaks extending from the Tbx18 promoter both upstream and 
downstream, over a distance of approximately 2 Mbp (Fig. 3.1). The highest peak density was 
found within a smaller region including Tbx18 neighbors 4922501C03Rik in the centromeric 
direction, to Snx14 and Syncrip located telomerically (Fig. 3.1A). This region corresponds roughly 
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to the boundaries of the topologically associating domains (TADs) determined for the Tbx18 
region in mouse and human Hi-C experiments (Fig. 3.1A) (Dixon et al.).  
 
Synteny is conserved in the human and mouse regions extending 1 Mbp downstream of Tbx18, 
suggesting that the same genes and elements are likely to be in influencing Tbx18 gene expression 
in both species. However, an evolutionary rearrangement has disrupted mouse-human synteny 
upstream of Tbx18, in the mouse telomeric direction. Specifically, Tbx18 and its downstream 
neighbors, as well as upstream genes up to and including Syncrip, are all similarly organized on 
human chromosome 6 (chr6). However, genes beyond Syncrip in mouse chr9 do not map to human 
chr6; instead they cluster together on human chr4. This evolutionary breakpoint coincides well 
with the telomeric ends of the experimentally determined, conserved mouse Tbx18 TAD (Fig. 
3.1A). The TAD contains approximately 10 broad peaks identifying the approximate locations of 
sequence elements in contact with the Tbx18 promoter in E18.5 UGS cells, detected with excellent 
reproducibility in the replicate experiments (Fig. 3.1, 4C tracks).   
 
3.3.2 Genome-wide Open Chromatin Maps Define Positions for Regulatory Elements within 
Tbx18 Promoter-contacting Peaks 
To more precisely delineate the locations of active enhancers within the broad 4C peaks, we carried 
out ATAC-seq, a transposase-based method that allows identification of open, or accessible 
chromatin positions genome-wide from small numbers of input cells (Buenrostro et al., 2015) 




Open chromatin profiles have not been published for UGS at any developmental stage, making 
quality genome-wide profiles potentially useful beyond the purposes of this study. To assess the 
quality of these data, we first asked whether the ATAC-seq peaks correlated well with genome 
features known to be associated with open chromatin marks in eukaryotic genomes (Supplemental 
Table 2). For example, as expected, E18.5 UGS ATAC-seq peaks were especially enriched near 
(within 2 kb of) the annotated promoters of genes expressed in the UGS genome-wide; 
furthermore, most of the peaks with the highest levels of ATAC-seq enrichment were promoter-
linked, as expected (Supplemental Table 2). Furthermore, ATAC-seq promoter peak height 
correlated roughly with previously determined E18.5 UGS gene expression levels ((Bolt et al., 
2016), Supplemental Table 2). Thus, the ATAC-seq peaks correlate well with features expected of 
open chromatin domains.  
 
In addition, a large number of less highly enriched non-promoter peaks were also detected 
throughout the genome, including in the Tbx18 TAD region (Supplemental Table 2; Fig. 3.1A, 
1B). All but eight of the ATAC peaks in the Tbx18 TAD region are well conserved in the human 
genome and overlap very well with ENCODE-analyzed DNase1 hyper-sensitive sites determined 
in a panel of human cell lines (Supplemental Table 2), suggesting conserved regulatory activity. 
One of these conserved ATAC-seq peaks with a DNase1 HS site, located under a distal 4C-peak 
positioned downstream of Tbx18, is contained within the previously defined ECR1 enhancer 
region, which lies near the end of Tbx18-containing BAC clone RP23-353o7 (Fig. 3.1B, 




3.3.3 Lineage Tracing Experiments Define Broad Functional Territories within the Tbx18 
TAD. 
These data defined a large active TAD with broad 4C peaks containing a significant number of 
potentially novel UGS enhancers. However, the UGS and closely apposed tissues (which would 
have been included in our dissections) is comprised of a mix of different cell types at E18.5. 
ATAC-seq and 4C-seq peaks could be contributed by any relatively abundant UGS cell type. At 
this developmental stage, undifferentiated mesenchymal cells comprise the predominant cell type, 
although epithelial cells, neurons, and other cell types are also present in the tissue samples. 
Enhancers can exist in various regulatory states: active, primed, and poised (Cruz-Molina et al., 
2017, Rada-Iglesias et al., 2011, Zentner et al., 2011). In agreement, the observed 4C peaks could 
represent cells in which Tbx18 is being actively expressed, repressed, or consisting of a constitutive 
architectural state at the E18.5 time-point. 
 
To define the cell types expressing Tbx18 at or around E18.5 with an eye toward later tracing the 
adult fates of those cells, we used a Cre-Lox based lineage-tracing approach.  For this purpose, we 
used a previously published mouse strain in which the Cre gene had been “knocked in” to exon 2 
of the native Tbx18 locus (Tbx18:Cre; (Cai et al., 2008)). We crossed this strain to animals carrying 
a ZsGreen (modified GFP) reporter gene held silent by a loxP-flanked upstream stop codon 
(Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze /J; (Madisen et al., 2010); hereafter abbreviated ZsG).  In 
animals carrying both the Tbx18:Cre and ZsG allele, Tbx18-expressing (Tbx18+) cells will be 
fluorescently labeled; once the floxed stop codon has been excised by Cre in a Tbx18+ precursor 




 We also employed lineage mapping for another purpose: that is, with the goal of subdividing the 
large Tbx18 TAD into subdomains harboring enhancers active in different subsets of UGS-
associated cells. Specifically, we used the 209 kb BAC transgene, described above (Tbx18:BAC-
icre), in which BAC RP23-353o9 has been modified by “knocking in” a Cre recombinase gene 
into the Tbx18 gene resident in the BAC, and used to create a transgenic mouse line (Wang et al., 
2009). As also mentioned, Tbx18:BAC-iCre drives reporter expression in a pattern that mirrors 
Tbx18 expression faithfully in many cell types and tissues, but does not recapitulate all native 
Tbx18 domains ((Wang et al., 2009) and see below). This finding is consistent with the fact that 
the BAC encompasses only a subset of Tbx18 promoter-contacting DNA elements (Fig. 3.1B).  
 
Using the Tbx18:Cre and Tbx18:BAC-iCre alleles in parallel thus offered the possibility of 
subdividing the Tbx18 TAD into functional subdomains. To test this strategy, we crossed animals 
carrying each allele to mice carrying the floxed ZsG reporter and collected tissues from doubly 
heterozygous offspring at different ages. We focused on reporter expression at E18.5, but also 
collected tissues at later stages with an eye toward identifying the adult fates of the Tbx18+ cells.  
We examined cell types contained within the UGS proper but also closely adherent cells that would 
have been included in gene expression and chromatin analysis. 
 
We previously reported that the Tbx18 transcript and protein are expressed in the UGS as early as 
E16.5 (Bolt et al., 2016). At this stage expression is limited to a cluster of UGS mesenchymal cells 
that closely surround dorsal and anterior portions of the prostatic urethra (Bolt et al., 2016). The 
Tbx18:BAC-iCre allele was also shown previously to drive low level expression from a floxed 
beta-galactosidase-expressing LacZ reporter gene in the UGS as early as E15.5 (Wang et al., 2009). 
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We examined ZsG expression driven both the Tbx18:Cre and Tbx18:Bac-iCre alleles at E16.5, 
and confirmed low levels of labeling concentrated in the dorsal and anterior regions of the prostatic 
urethra, very similar to the pattern reported previously (Bolt et al., 2016).    
 
Also consistent with quantitative RT-PCR (qRT-PCR) and immunohistochemistry (IHC) data 
indicating peak Tbx18 UGS expression around the time of birth (Bolt et al., 2016), we also detected 
high levels of ZsG labeling in UGS sections from animals carrying the native Tbx18:Cre knock-
in together with the floxed ZsG allele (Tbx18:cre/+, ZsG/+) at E18.5. We first examined transverse 
sections taken from a relatively anterior position, near the base of the bladder where the prostate 
buds have begun to form.  At this stage and in this location, Tbx18:Cre-driven ZsG labeling was 
widespread throughout the UGS mesenchyme in both dorsal and ventral directions, including cells 
surrounding the base of the seminal vesicles (SV) and ejaculatory ducts (ED), around the prostatic 
urethra (UR), and around the buds of prostatic epithelium extending into the mesenchyme 
(arrowhead in Fig. 3.2A). In contrast, the Tbx18:BAC-iCre allele drove ZsG expression primarily 
in the dorsal portions of the UGS in comparable anterior sections, with limited ventral labeling 
(Fig. 3.2B).  
 
In more posterior sections of Tbx18:Cre/+, ZsG/+ UGS, ZsG expression was driven in cells 
forming a ring surrounding the urethra (Fig. 3.2E). However, this domain of ZsG expression was 
not detected in the Tbx18:BAC-iCre, ZsG+ embryos (Fig. 3.2F). The ring of cells labeled by 
Tbx18:Cre yielded a strong positive signal when the sections were stained with an antibody to 
myosin heavy chain, a marker for skeletal muscle, confirming that the ring of cells labeled 
exclusively in Tbx18:Cre/+, ZsG/+ embryos are skeletal muscle precursors (yellow cells in Fig. 
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3.2E). The ring of MHC+ cells was arranged similarly to those that will later give rise to the 
skeletal muscle of the rhabdosphincter (Sebe et al., 2005, Borirakchanyavat et al., 1997, Oelrich, 
1980) (Fig. 3.6C), suggesting that Tbx18 is expressed in cells destined for the rhabdosphincter fate.  
 
Also labeled by the endogenous Tbx18:Cre knock-in but not by the Tbx18:BAC-iCre allele was 
the loose band of mesenchymal cells exterior to but in close apposition to the UGS (Fig. 3.2G, 
3.2I); both Cre alleles labeled the mesothelial lining around the developing organ (Fig. 3.2H. 3.2J).  
Although the identification of Tbx18 expression in skeletal muscle cells was surprising, each of 
these cell types is mesenchymally derived. Even more surprisingly, however, we found clear 
examples of ZsG labeling driven from both of the Cre alleles in cells of other embryonic types. 
For example, the Tbx18:Cre drove expression of the floxed ZsG reporter in urothelial cells forming 
the inner lining the prostatic urethra (Fig. 3.2C); these cells were not labeled by the Tbx18:BAC-
iCre (Fig. 3.2D).  Moreover, with both Cre alleles, we saw ZsG expression in the pelvic ganglia 
(PG), which develop to provide the major innervation of the bladder and prostate (Keast, 2006). 
Like other peripheral ganglia, PG cells are of neural crest origin (Wiese et al., 2012b, Wiese et al., 
2017) an embryonic lineage not previously linked to Tbx18 activity. Widespread ZsG labeling was 
detected in PG with the Tbx18:Cre at E18.5, with stronger expression driven by the transgenic 
Tbx18:BAC-iCre allele but in a more limited number of PG cells (Figs. 3.2A, 3.2B; Figs. 3.3A, 
3.3D).    
 
The ZsG+ cells in the PG were of two types at this stage in both animals: (1) round cells with large 
nuclei and cell bodies, and (2) elongated cells, many of which appeared to encase the large round 
cells (Fig. 3.2A, 3.2B; Fig. 3.3A, 3.3D).  In the PG, these different cell shapes are associated with 
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(1) progenitor cells or differentiated neurons and (2) satellite glia, which wrap and protect 
sympathetic neurons either singly or in clusters, respectively (Armati and Mathey, 2013).  The 
majority of ZsG+ cells were of the latter type, although especially in the Tbx18:BAC-iCre images, 
rounds cells were also brightly labeled with ZsG (Figs. 3.3A, 3.3D). We asked whether these round 
cells were neurons or undifferentiated progenitors by staining sections with NeuN, an established 
marker for differentiated neuronal cells. In both cases, a subset of the NeuN+ cells were also 
labeled with ZsG, more in number in the Tbx18:BAC-iCre sections than for the Tbx18:Cre samples 
(arrowheads in Figs. 3.3C, 3.3F).  In sections from animals of both genotypes, the elongated glial 
cells were labeled with ZsG but did not co-stain with NeuN, as expected. However, in both cases, 
we detected NeuN+ cells without ZsG label. These data suggested that the Tbx18:Cre and 
Tbx18:BAC-iCre drive expression in progenitor cells somewhere along the path to the 
commitment to neuron or glial cell lineages, with the fate of labeled cells biased toward the satellite 
glial cell fate. 
   
3.3.4 Adult Fates of Tbx18-expressing UGS Cells  
To better understand the identities of labeled cell types, and in particular the ultimate fates of those 
cells, we also examined prostates and closely associated supporting tissues from adult animals. 
Both Cre alleles labeled cells in the fibromuscular stroma of the prostate lobes, particularly in 
urethral-proximal regions of the anterior and dorsolateral lobes (Figs. 3.4A-F). In animals carrying 
either Cre allele, ZsG-labeled cells corresponded to both major prostate stromal cell types, 
fibroblasts and SMC, as evidenced by staining with vimentin (VIM), and smooth muscle actin 
(SMA) antibodies, respectively (Figs. 3.4G-J).  We also detected bright ZsG labeling in other cell 




For example, in the prostate epithelial compartment we detected isolated, dispersed cells in both 
genotypes; staining with the serotonin (5-HT) antibody revealed all of these to be the 
neuroendocrine cells (NEC) of the prostate (Figs. 3.5E-F, arrowheads). Like cells within the PG, 
NEC are derived from neural crest precursors (Szczyrba et al., 2017), making this a second type 
of Tbx18+ cells of this lineage.  Within the adult pelvic ganglia, most ZsG+ cells were of the 
satellite glial type, stretched around neuronal cells in a continuous, elongated layer (Fig. 3.5C), 
stained with s100, a marker for satellite glia (Yan and Keast, 2008).  These elongated cells were 
also labeled with ZsG+ in the Tbx18:BAC-iCre animals (Fig. 3.5D); additionally, and uniquely in 
the Tbx18:BAC-iCre, ZsG+ mice, the cell bodies of large, round cells were labeled (Fig. 3.5Bi).  
These round cell bodies also tested positive for NeuN (Fig. 3.5Bii) indicating that, Tbx18:BAC-
iCre actively drives Cre expression in precursors of both pelvic ganglion satellite glia and neuronal 
cells. We also saw lineages of both Tbx18:Cre and Tbx18:BAC-iCre in cells around blood vessels 
(data not shown).  
 
Looking at other cell types closely associated with the prostate but not integral to it, we detected 
very strong ZsG labeling in the adult adipose tissue with the Tbx18:Cre allele (Fig. 3.6A). ZsG 
was also detected within the same periprostatic adipose depots in Tbx18:BAC-iCre, ZsG+ mice, 
but in significantly fewer cells and at much reduced intensity (Fig. 3.6B). This difference suggests 
that mesenchymal cells destined to differentiate into prostate-associated adipocytes express Cre 
from the native Tbx18 allele, but not, or significantly less so, from the Tbx18:BAC-iCre transgene.  
The exact origins of these fat depots is not clear, but they should be derived from a mesenchymal 
cell type not labeled with the Tbx18:BAC-iCre allele. Candidate tissues thus include the loose 
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band of mesenchymal cells surrounding the UGS at E18.5 (Fig. 3.2G), or possibly, cells of the 
anterior/ventral regions of the E18.5 UGS. Alternatively, the periprostatic fat cells could be 
derived from cells outside the UGS proper, or from cells that express Tbx18 after E18.5. Whatever 
their origins, these data show that Tbx18 is expressed in cells that are fated to become periprostatic 
fat.  
 
A final stark difference between the two Cre-expressing alleles was observed in the very strong 
labeling of skeletal muscle cells of the external rhabdosphicter in mice driving ZsG from 
Tbx18:Cre (Fig. 3.6C); these muscle cells were not labeled in animals expressing ZsG from the 
Tbx18:BAC-iCre driver (Fig. 3.6D). This result is consistent with activities of the two Cre alleles 
in the ventrally- and caudally-located ring of mesenchymal cells at E18.5 (Figs. 3.2E, 3.2F), and 
confirms the Tbx18+ origins of those skeletal muscle cells. 
 
3.3.5 The ECR1 Enhancer is Expressed in Developing Prostate 
Together these data define cell types expressing Tbx18 in the E18.5 UGS, including a majority of 
mesenchymal cells with a surprising variety of adult cell fates, but also a less numerous but 
nonetheless significant population of cells derived from the neural crest. The comparison between 
expression driven by Tbx18:Cre and the Tbx18:BAC-iCre transgene allow us to divide the Tbx18 
TAD region into rough functional domains, including enhancers within the boundaries of the BAC 
transgene or beyond its limits, either upstream or downstream of the Tbx18 gene (Fig. 3.8). Thus, 
we can surmise that elements functional in the population of UGS mesenchymal cells that give 
rise to most prostate-associated adipose tissue and skeletal muscle in the external rhabdosphincter, 
map outside the region spanned by BAC RP23-353o7. On the other hand, enhancers required for 
68 
 
expression of Tbx18 in stromal fibroblasts and SMC, neuroendocrine cells within the prostate 
epithelial compartment, and satellite glia within the pelvic ganglia appear to all be contained within 
the 209 kb BAC region (Fig. 3.8).  
 
Previously, we leveraged the fact that the 12Gso translocation breaks just within the region 
spanned by BAC RP23-353o7 to identify the ECR1 enhancer, which is required to maintain 
expression of Tbx18 in later embryonic stages of ureter development (Bolt et al., 2014). 
Interestingly, the ECR1 sequence also includes the only ATAC peak we found within the most 
distal 4C peak included in the BAC (Fig. 3.1B). These data suggested that ECR1 is active in 
developing UGS as well as in the ureter. The enhancer marked by the E18.5 UGS ATAC-seq peak 
is at the centromeric end of ECR1, and thus located just beyond the 12Gso breakpoint site (Fig. 
3.1B). Along with any other enhancers downstream of the translocation breakpoint, separation of 
this ECR1-encompassed enhancer from the Tbx18 promoter could thus play a functional role in 
the prostate phenotype we detected in Tbx18 mutant mice (Bolt et al., 2016).  
 
We showed previously that ECR1 drives expression in developing ureteric mesenchyme by 
analyzing expression of a transgenic construct containing this sequence element, cloned upstream 
of a LacZ-expressing enhancer reporter (Bolt et al., 2014). To ask whether ECR1 is expressed in 
developing prostate, we collected UGS from the same transgenic line and stained the sectioned 
tissue with the colorimetric reporter X-gal. 
 
The data confirmed that ECR1 indeed can drive reporter expression in the E18.5 UGS. Enhancer 
activity is highest in the mesenchymal cells clustered closely adjacent to and dorsal of the prostatic 
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urethra, in a pattern very similar to the Tbx18 expression pattern at E16.5 (Fig. 3.7C).  Transverse 
sections collected from anterior to posterior positions (rostrally-to-caudally) throughout the E18.5 
UGS of ECR1 transgenic mice provided a three-dimensional view of the enhancer’s activity. 
Mesenchymal cells scattered around the UGS mesenchyme and just beginning to condense around 
the distal tips some prostatic buds were also labeled by the ECR1-driven reporter, although at 
much less intense levels than the urethra-proximal cells at this developmental stage (Fig. 3.7E). 
These LacZ-expressing mesenchymal cells represent a subset of the expression pattern driven by 
the Tbx18-BAC-iCre allele at this same time point (Fig. 3.2B, refer to ZsG staining), consistent 
with the fact that ECR1 sequence is contained within the region spanned by BAC RP23-353o7. In 
addition, a small number of cells were labeled in the E18.5 pelvic ganglia; in this case, the cells 
labeled by ECR1 corresponded to much smaller number than labeled by the BAC transgene (Fig. 
3D). These data indicate that promoter-contacting sequences within this downstream 4C peak 
contain an enhancer driving Tbx18 expression in urethral-proximal mesenchymal cells in the E18.5 
prostates and a subset of pelvic ganglion cells. 
 
3.3.6 Lineages of TBX18+ Cells in the Dorsal Root Ganglia (DRG) of the Spinal Cord 
The surprising expression of Tbx18 in neuroblasts in the Pelvic ganglia and Neuroendocrine cells 
raised the question about expression this TF in other neural crest derived cells in the embryo. We 
found strong expression of Tbx18 in the Dorsal root ganglia (Fig. 3.9) located on either sides of 
the spinal cord and forms a metameric pattern along the anterior-posterior (AP) axis of the embryo 
(Teillet et al., 1987). They are neurons derived from the trunk neural crest cells and are part the 
sensory pathway that are activated by stimuli and transit sensory messages of pain and touch to 
the central nervous system (Kasemeier-Kulesa et al., 2005). Specifically, we see expression in 
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these neurons are driven by ECR1 (Fig. 3.9B), a regulatory element that was also active in the 
pelvic ganglion (Fig. 3.7G). The Tbx18:BAC-icre expression is also seen in these neurons (Fig. 
3.8D).  
 
3.4 DISCUSSION  
Previous studies have pointed to a large and complex regulatory domain for the Tbx18 gene (Bolt 
et al., 2014), and the primary purpose of this study was to define the reach, subdomain structure, 
and cell type-specific regulatory activities within this domain in developing prostate. The data 
confirm that in E18.5 UGS, the Tbx18 promoter is in contact with chromatin elements spread over 
a large domain, corresponding well in both size and position to the regional topologically 
associating domain determined by Hi-C experiments in human and mouse (Dixon et al., 2012). 
Within the broad 4C peaks, ATAC-seq peaks highlighted smaller regions of accessible chromatin, 
suggesting more precisely the positions of potential active enhancer elements active in the UGS at 
E18.5. Since most of these accessible elements in the Tbx18 region are conserved and correspond 
to DNase1 hyper-sensitive sites in human cells, homologous sequences are likely to correspond to 
enhancers driving Tbx18 expression during human prostate development as well. To our 
knowledge, this is the first report of accessible chromatin elements in the UGS at any 
developmental time point or in any species, and these data thus provide a resource with potential 
utility beyond the specific aims of this work. 
 
Our original expectation was that Tbx18-expressing UGS cells would correspond primarily to 
mesenchymal cells destined to develop into stromal smooth muscle cells and fibroblasts of the 
anterior and dorsolateral prostate lobes – which, we have shown, are grossly abnormal in Tbx18 
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mutant adults (Bolt et al., 2016). We therefore expected the chromatin data we generated to 
represent that particular class of mesenchymal precursor cells. Mesenchymal precursors do indeed 
represent the primary Tbx18+ UGS cell type at this stage, although lineage studies have revealed 
that these precursor cells adopt a surprisingly wide variety of adult cellular fates. Most of the adult 
cell types labeled strongly by Tbx18:Cre in adults - stromal smooth muscle cells, fibroblasts, and 
periprostatic adipose – develop postnatally, and their precursors remain undifferentiated at E18.5 
(Georgas et al., 2015). The Tbx18+ cells at this stage might therefore reasonably be expected to 
present relatively consistent gene expression and chromatin profiles. 
 
Nevertheless, several lines of evidence suggest that the Tbx18+ UGS mesenchymal precursors are 
not identical, even at this early stage. For example, as illustrated by ECR1, specific enhancers may 
be active only in spatially restricted subsets of these cells. Even more strikingly, mesenchymal 
cells forming the ventral and posterior ring around the urethral have already begun to express the 
myosin heavy chain protein by E18.5 and to display signs of striation, indicating that these cells 
are already committed to the skeletal muscle fate. These rhabdosphincter precursors are relatively 
numerous and are thus likely to contribute unique chromatin and gene expression patterns to the 
composite tissue signals. 
 
The very strong labeling of rhabdoshincter cells was a major surprise to arise from our lineage 
tracing studies, because Tbx18 has not been reported to be expressed in skeletal muscle precursors 
in the past. However, compared to other skeletal muscle types, rhabdosphincter cells have an 
unusual origin and differentiation history. Specifically, these cells are derived from splanchnic 
rather than from somatic mesenchyme, reportedly sharing a common embryonic precursor with 
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smooth muscle cells of the lissopshincter (Sebe et al., 2005). Rhabdosphincter skeletal muscle cells 
have been reported to transdifferentiate from smooth muscle, a highly unusual origin for skeletal 
muscle cells (Borirakchanyavat et al., 1997). Rhabdosphincter is central to stress urinary 
continence and thus of significant medical importance (Koraitim, 2008), and the developmental 
trajectory of these cells remains uncertain (Georgas et al., 2015). The identification of Tbx18 as a 
transcription factor that is active in the precursors of rhabdosphincter cells may thus provide a 
useful tool for future studies as well as be used as a good lineage marker for this muscle. 
 
Even more surprisingly, we identified Tbx18+ cells that are of embryonic lineages not previously 
associated with Tbx18. These include a limited number of cells of endodermal origin, which form 
the inner epithelial lining of the embryonic prostatic urethra; we detected no labeling of urethral 
epithelium or known derivative cells in adults, suggesting either that this Tbx18+ population is 
transient, or that they adopt adult fates that are currently undocumented. A second, more numerous 
group of cells expressing Tbx18 at E18.5 are known to be derived from the neural crest; these 
include particularly the precursors of satellite glia in the pelvic ganglia but also the neuroendocrine 
cells that are sparsely distributed throughout the adult epithelial compartment. The cells giving 
rise to satellite glia are weakly labeled by the Tbx18:Cre at E16.5 (data not shown), but are very 
strongly labeled by E18.5, indicating active Tbx18 expression at or just before this later 
developmental stage. The origins of neuroendocrine cells and when Tbx18 might be expressed in 
those cells was not captured in this study. This is the first report of Tbx18 expression in neural 
crest-derived cells in any tissue and suggest further investigation of the T-Box protein’s role in 
their differentiation and function. Glial progenitor cells are particularly interesting in the context 
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of this study, since they are present in enough numbers to contribute to significant signals in both 
chromatin and expression data discussed here. 
 
With two Tbx18 Cre alleles used for lineage-tracing studies, we were also able to partition the 
Tbx18 TAD into regional subdomains housing regulatory elements expressed in specific 
subpopulations of cells.  Expression of Cre from the endogenous Tbx18 allele marks the full range 
of cell types summarized above.  Cre driven by the Tbx18:BAC-iCre transgene, representing 
genomic material that surrounds Tbx18 by 209 kb, also labels many of these cell types suggesting 
that active enhancers required for Tbx18 expression in these cells are present within the BAC. 
However, rhabdosphincter precursors or most cells giving rise to periprostatic fat are not labeled 
by the Tbx18:BAC-Cre transgene, suggesting that enhancers required for Tbx18 expression in 
precursors to those cell types lie outside the 209 kb BAC region (Fig. 3.8).  
 
Another distinction between the Tbx18:Cre and Tbx18:BAC-iCre alleles concerns the fates 
assumed by labeled cells in the pelvic ganglia in adult. In particular, the Tbx18:BAC-iCre allele 
appears to strongly label differentiated neurons, while the endogenous Tbx18:Cre does not. While 
other explanations are possible, we hypothesize that this difference may suggest the presence of a 
repressor element located outside the region spanned by the BAC, which serves to silence Tbx18 
expression in common neuron-glia precursors after their commitment to the neuronal fate. The 
other explanation of this difference could be that the Tbx18:BAC-iCre is turned on earlier in the 
neuron-glia precursor lineage due to the absence of a repressive element outside the BAC region 
than the native Tbx18:Cre allele, and so marks both the neurons and glial cells. Future experiments 




In addition to lending information regarding regulatory domain structure, lineage tracing studies 
reveal novel information that further inform the role of Tbx18 in urogenital development and 
health. In particular, we had interpreted the prostate phenotype in Tbx18 mutants as resulting from 
a failure of the Tbx18+ precursors of stromal smooth muscle cells and fibroblasts to differentiate 
appropriately (Bolt et al., 2016). These stromal cells are clearly malformed in the mutant mice, 
and their developmental failure could explain epithelial abnormalities through the disruption of 
essential mesenchymal:epithelial signaling (reviewed by  (Cunha, 2008)) and through 
inflammatory signals generated by the myofibroblasts that appear instead of differentiated smooth 
muscle cells (Tuxhorn et al., 2002).   
 
However, Tbx18+ precursors give rise to a much wider range of cell types, including several 
known to strongly impact prostate epithelial development, growth and maintenance in adults, and 
these must now be taken into account. For example, Tbx18+ cells of mesenchymal origin directed 
to blood vessels and periprostatic fat depots could each contribute significantly to prostate 
epithelial health (Zahalka et al., 2017, Hayakawa and Wang, 2017, Laurent et al., 2016).  
Furthermore, satellite glia are essential to the survival and function of pelvic ganglion neurons 
(reviewed by (Armati and Mathey, 2013), and dysfunction of these neurons has in turn been 
associated with prostate disorders (Wang et al., 1991, McVary et al., 1994, Thiyagarajan, 2002, 
Zahalka et al., 2017, Hayakawa and Wang, 2017). Neuroendocrine cells are also essential to the 
health of the prostate epithelium, providing neuropeptide hormones with profound effects on 
epithelial function and growth (Abrahamsson and di Sant'Agnese, 1993, Gkonos et al., 1995). 
These data suggest many paths through which Tbx18 dysfunction might directly affect the 
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development growth or maintenance of prostate epithelia throughout the lifespan. Fortunately, 
these paths can be examined individually through conditional knockouts and appropriate Cre 
alleles.  
 
Lineage tracing studies also revealed potential roles for Tbx18 that may be highly relevant to 
urogenital health. Specifically, the very high and uniform expression of Tbx18 in mesenchymal 
cells giving rise to the rhadbdosphincter, a tissue that is independently critical to urogenital health, 
suggest that Tbx18 could be involved in development of other types of important lower urogenital 
tract disorders.  
 
Finally, we show that an enhancer driving Tbx18 expression in the developing ureter (Bolt et al., 
2014) is also active during early stages of prostate development. ECR1 is active in a subset of the 
dorsal mesenchymal cells that are labeled with the Tbx18:BAC-iCre, consisting primarily of a tight 
band of cells cluster just dorsal and adjacent to the prostatic urethra. This expression subset makes 
sense, since ECR1 is wholly contained within the boundaries of the BAC transgene (Bolt et al., 
2014). In fact, the ECR1 expression pattern resembles the earliest pattern of expression we detected 
with a TBX18 antibody, which is also tightly clustered in this dorsal position at E16.5. We thus 
conjecture that ECR1 may be expressed in this domain before the E18.5 timepoint, remaining 
active in this location through later stages when the Tbx18 expression domain increases to include 
a wider swath of UGS mesenchymal cells. Previously we had shown a conserved Lef1 binding site 
in ECR1 (Bolt et al., 2014) and other studies in the ureter have suggested a role of canonical WNT 
signaling in maintaining expression of Tbx18 in the condensing mesenchyme around ureteric buds 
(Airik et al., 2006, Trowe et al., 2012). This data along with our observation of ECR1 expression 
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at E18.5 resembling the early pattern of expression of Tbx18 (detected with antibody staining at 
E16.5), suggests that WNT signaling maintains Tbx18 expression at E18.5 around the condensing 
prostatic buds through activation of ECR1.  
 
Our observation of the expression of Tbx18 in the DRGs is the first report of this gene implication 
in the development and differentiation of these cells. In addition, the expression of ECR1 reporter 
in these cells, have identified a novel enhancer that drives expression of TF in these neurons. We 
have been able to successfully generate mutants of the genotype Tbx18:BAC-iCre, Tbx18Flox/Flox, 
where the  knockout of Tbx18 is driven by the subset of regulatory elements that is contained 
within the 209kb BAC. These animals display a hind-limb clasping phenotype, seen consistently 
across 10 animals of this genotype. The morphology of the hind-limb is completely normal 
suggesting the clasping phenotype is due to defects in the innervations or sensory pathways of the 
DRGs supporting this limb. Future work on the function of Tbx18 in the DRGs will tell us identify 
a novel role of this gene in neurons.  
 
The ATAC-seq peaks underlying the major 4C contact points suggest locations of additional 
enhancers that interact with the Tbx18 promoter and drive expression in additional mesenchymal 
and neural crest-derived domains. Future studies will be focused on exploiting this resource for a 







Figure 3.1 4C-seq and ATAC-seq reveal the regulatory structure of the Tbx18 locus in E18.5 
male urogenital sinus. (A) 4C-seq using a viewpoint located at the Tbx18 promoter (red line) 
shows the Tbx18 topologically associating domain extends over a 1.5Mbp region. The asterisk (*) 
indicates a strong interaction peak with the Tbx18 promoter. This peak contains the ECR1 
enhancer. The indicated TADs are from (Dixon et al., 2012) and (Lieberman-Aiden et al., 
2009).The two 4C tracks are biological replicates. See Methods section for details on the scaling 
and smoothing of the 4C. The bottom track of (A) is ATAC-seq for the region. (B) Expansion of 
the portion of the Tbx18 locus included in the BAC RP23-353o7. ATAC-seq indicates multiple 
putative enhancer elements in this subregion. The ECR1 enhancer, which encompasses the 12Gso 
breakpoint is indicated. This region is also a strong contact for the Tbx18 promoter and includes a 







Figure 3.2 E18.5 UGS lineage tracing using Tbx18:Cre and Tbx18:BAC-iCre alleles. 
Immunofluorescence (A-D, G-J) and Immunohistochemistry (E, F) of transverse sections at E18.5. 
Cre-expressing lineages are marked by ZsGreen (ZsG; Green) and nuclei are counter-stained with 
Hoechst (Blue). The Tbx18:Cre allele gives rise to strong and widespread ZsG labeling in the 
anterior UGS mesenchyme (A) in contrast to Tbx18:BAC-iCre which labels cells only in regions 
dorsal to the UR (B). White arrowheads mark anterior buds (A, B). Surface urethral epithelial cells 
are labeled by the Tbx18:Cre (C) but not by Tbx18:BAC-iCre allele (D). Tbx18:Cre lineage 
labeling is intense in a ring of posteriorly located muscle cells that becomes the rhabdosphincter 
(E) but Tbx18:BAC-iCre does not label these cells (F), which stain positive for the Myosin heavy 
chain antibody (MHC; in red). The loose mesenchyme surrounding the UGS is labeled with 
Tbx18:Cre (G) but not Tbx18:BAC-iCre (I); see Fig. 3.6A, 6B. Mesothelium, marked by white 
arrowheads (H, J) is marked by both Cre alleles. Abbreviations DD: Ductus deferens; PG: Pelvic 





Figure 3.3 Cells marked by Tbx18:Cre and Tbx18:BAC-iCre alleles in the E18.5 Pelvic 
Ganglia. Immunohistochemistry of transverse sections of the pelvic ganglia at E18.5 with the 
NeuN antibody identify the presence of differentiated neurons. Lineages labeled with the 
endogenous Tbx18:Cre and the Tbx18:BAC-iCre alleles are marked by ZsGreen (Green) and 
nuclei are counter-stained with Hoechst (Blue). The Tbx18:Cre allele marks a larger population of 
cells in the pelvic ganglia including a few that co-stain lightly with the neuronal marker NeuN 
(white arrowheads in A, B, and C). Tbx18:BAC-iCre also labels cells in the E18.5 pelvic ganglia, 






Figure 3.4 Adult lineages labeled by Tbx18:Cre and Tbx18:BAC-iCre alleles in the prostate. 
Cre-expressing lineages are marked by ZsGreen (Green) and nuclei are counter-stained with 
Hoechst (Blue). Panels marked by roman numeral ii (Aii-Fii) are high resolution images crops of 
areas marked by arrowheads in the corresponding roman numeral i panels (Ai-Fi). Tbx18:Cre 
labels cells the prostatic stroma derived from mesenchymal cells in the Anterior lobe (A), and 
Dorso-lateral lobe (C) but not in the ventral lobe (E). The Tbx18:BAC-iCre allele, in contrast, 
labels stromal cells in all three lobes (B, D,F). Immunohistochemistry of the stroma cells using 
antibodies that are markers verify the identity of the cell types (G-J). Tbx18:Cre and Tbx18:BAC-
iCre label the smooth muscle cells (G, I), marked by smooth muscle actin (SMA), and fibroblasts 
(H, J), stained with marker Vimentin (VIM). White arrows point to overlap of lineage-traced cells 






Figure 3.5 Tbx18:Cre and Tbx18:BAC-iCre expressing cells give rise to adult neurons and 
glia. Cre-expressing lineages are marked by ZsGreen (Green) and nuclei are counter-stained with 
Hoechst (Blue). Tbx18:Cre and Tbx18:BAC-iCre strongly label lineages in the pelvic ganglia (A-
D) as well as neuroendocrine cells (E, F) in the prostate epithelial compartment. Panels A-D 
include sub-panels marked with roman numerals that are the same section imaged with different 
wavelength channels. Tbx18:Cre does not label mature neurons in the pelvic ganglia, which are 
stained with the neuronal NeuN antibody (Aii), although these mature neurons are labeled by the 
Tbx18:BAC-iCre (Bii); white arrows. All cells marked in the pelvic ganglia by the Tbx18:Cre are 
satellite glia cells that wrap around the neurons, detected with marker S100 (Ci-iii). Tbx18:BAC-
iCre also labels the satellite glia (Di-iii); white arrowheads. In addition, both Cre alleles mark 
neuroendocrine cells within the prostate epithelial compartment strongly (E-F), as confirmed by 
staining with an antibody to Serotonin (5-HT). Panels (Eii, Fii) are high resolution images crops 
of their corresponding panels (Ei, Fi) with arrowheads pointing to neuroendrocrine cells. Scale 






Figure 3.6 Tbx18:Cre and Tbx18:BAC-iCre differentially mark adult periprostatic adipose 
cells and skeletal muscle of the rhabdosphincter. Cre-expressing lineages are marked by 
ZsGreen (Green) and nuclei are counter-stained with Hoechst (Blue). Periprostatic fat and 
rhabdosphincter are each marked strongly by Tbx18:Cre (A, C) but not by Tbx18:BAC-iCre (B, 
D) respectively. E, G are high magnification crops of C, D showing striations in the muscle. The 
striated Tbx18:Cre-labeled rhabdosphincter cells stain very strongly with the Myosin heavy chain 
antibody, a marker for striated muscle (F) but these cells are not labeled with Tbx18:BAC-iCre. 









Figure 3.7 ECR1 expression in the E18.5 UGS. Using the Ecr1-Lacz transgenic animals we 
examined expression of the enhancer in thet E18.5 UGS using βgal staining. Whole-mount sections 
showed strong expression in the UGS (A, B). To identify cell types and regions expressing LacZ, 
βgal staining was done on 10μm sections (C-G). ECR1 expression is highest in the mesenchyme 
located just dorsal to the prostatic urethra (C, D, E). Mesenchymal expression is also detected 
around the prostatic buds (E, F; black arrow in E points to a dorso-lateral bud). ECR1 expression 






Figure 3.8 Regulatory map of the Tbx18 locus divided into 2 broad regions. Comparison of 
the cell lineages of the two Cres at E18.5 and in adults gives us the lineages controlled by the 
regulatory elements contained inside the 209kb BAC. The Tbx18-Bac-iCre region captures most 
of the cell fates, except the striated muscle, loose mesenchyme, ventral mesenchyme and the 
urothelium at E18.5. This suggests that the enhancer for these cell fates lie outside the BAC, but 
within the 1.5Mb TAD. In addition we hypothesize that as Tbx18:Cre lacks lineages in Neurons 
there is a repressive element contained outside the BAC region. The 4.5kbp regulatory element 
ECR1 close to the end of the BAC is expressed by a subset of the cells expresses by the BAC 





Figure 3.9 Tbx18 lineages in the Dorsal Root Ganglia (DRG) at E18.5. Tbx18 lineages are 
seen in the neurons in the DRG at E18.5 (A). ECR1 drives expression of Tbx18 in these neurons 
as seen by expression of this regulatory element (B). The number of cells in the DRG are lower 
in the Tbx18:Cre/Cre mutant (C). The Tbx18:BAC-icre is also expressed in these neurons (D).   
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Chapter 4  
WT1 PLAYS A KEY ROLE AS A TRANSCRIPTIONAL REGULATOR IN THE 
DEVELOPMENT OF THE UROGENITAL SINUS 
 
4.1 INTRODUCTION 
The zinc-finger transcription factor (TF) gene, Wt1, was originally identified for its association 
with Wilms Tumor, a devastating type of pediatric kidney cancer (Call et al., 1990, Gessler et al., 
1990).  Later studies confirmed an essential role for Wt1 in development of the kidney, heart and 
other organs, where it regulates epithelial-to-mesenchymal transition (EMT) or the reverse 
process, MET, as essential steps in establishing those tissues (reviewed by (Chau and Hastie, 
2012)).  During early kidney development, Wt1-positive (WT1+) mesenchymal cells condense 
around the epithelial cells of the invading ureteric bud, and subsequently undergo MET to give 
rise to epithelial cells of the nephron (Stark et al., 1994, Kreidberg et al., 1993).  Continued Wt1 
expression is essential for homeostasis and repair in kidney and a variety of other tissues, as 
evidenced by the glomerulosclerosis and multiple organ failure that results from ablation of Wt1 
expression in adult mice (Chau et al., 2011).   
 
While Wt1 expression drives MET during kidney development, WT1+ epicardial cells undergo 
EMT to give rise to cardiac smooth muscle and fibroblasts (von Gise et al., 2011).  The decision 
of WT1+ cells to proceed toward MET or EMT is driven by positive or negative regulation, 
respectively, of Wnt4, which is a direct regulatory target of WT1 protein (Sim et al., 2002). 
Although originally described as a transcriptional repressor, WT1 can exert either positive or 
negative effects on target genes depending on tissue context. For example, WT1 activates or 
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represses Wnt4 expression through recruitment of different cofactors and the establishment of 
distinct chromatin architectures (Essafi et al., 2011, Dong et al., 2015). Further complicating the 
functional picture, an alternative isoform of WT1, called +KTS, is a cytoplasmic protein that 
functions not in the regulation of transcription but in mRNA splicing (reviewed by (Ullmark et al., 
2018)). 
 
Wt1 has not been implicated previously for a role in prostate development. One study did show 
expression in the UGS mesenchyme in human embryo at 7wks and eluded to a possible relation 
between Wt1 to Androgen Receptor signaling (Kohler et al., 2007). Intriguingly, the inappropriate 
activation of WT1 is associated with EMT and aggressive prostate cancer in humans (Fraizer et 
al., 2016, Devilard et al., 2006).  Furthermore, in our previous analysis of the activities of T-box 
transcription factor, Tbx18, we noted significant expression of Wt1 in the embryonic urogenital 
sinus (UGS), from which the prostate develops (Bolt et al., 2016). Furthermore, our data showed 
that Wt1 expression is significantly dysregulated in Tbx18 mutant UGS at embryonic day E18.5, 
soon after the prostate epithelial buds first emerge; the expression of Wt1 at this stage and potential 
parallels with ureteric bud development drew our attention, particularly because Wt1 and Tbx18 
interact genetically other tissues (Takeichi et al., 2013, Norden et al., 2012). Because the genetic 
ablation of Tbx18 is associated with the later development of stromal and epithelial abnormalities 
in proximal regions of the anterior prostate lobe (Bolt et al., 2016), we hypothesized that Wt1 
contributes to the Tbx18 phenotype. We also considered that Wt1 might play an independent role 




To address these possibilities, we characterized Wt1 expression and the fate of WT1+ cells in 
developing prostate. We show that Wt1 is expressed in the UGS mesenchyme as early as E15.5, 
transitioning to epithelial expression by postnatal day 4 (P4) before declining to low levels at later 
adult stages. Using lineage tracing methods, we show that WT1+ cells contribute to a large fraction 
of epithelial cells in adults, in all the prostate lobes. In addition, a fraction of WT1+ cells maintain 
their original mesenchymal characteristics, giving rise to periductal fibroblasts.  Since Wt1-/- mice 
die prenatally, we examined prostate structure and integrity in heterozygous Wt1-/+ mice.  We 
confirmed that the prostate develops normally in these animals, with normal numbers, sizes, and 
branching of epithelial buds in the first 4-5 weeks of life. However, we found that Wt1 
haploinsufficiency has a surprisingly strong and consistent effect on prostate integrity, including 
epithelial disorganization. Further, we used a prostate-specific Cre, Pbsn:Cre (Wu et al., 2001a), 
together with a “floxed” Wt1 allele, Wt1Flox (Martinez-Estrada et al., 2010), to generate 
homozygous Wt1 mutants of the prostate Pb:Cre4+, Wt1Flox/Flox. This homozygous prostate-
specific ablation is associated with a severe prostate defect in the dorso-lateral and ventral lobes 
in adults, confirming a crucial role of Wt1 in prostate development. 
 
We probed the mechanisms through which this pathology develops by examining gene expression 
in Wt1-/+ prostates at P1, when the majority of the Wt1 expression is mesenchymal, and at P4, 
when expression has begun in epithelial cells.  We combined these studies with chromatin 
immune-precipitation followed by deep sequencing (ChIP-seq) to compare WT1 binding and 
target gene expression at these stages. Together these data outline a novel role for Wt1 in 




4.2 MATERIALS AND METHODS 
4.2.1 Histopathology and Immunohistochemistry. 
Tissues were dissected at the appropriate gestational or postnatal stage. Tissues were fixed in 4% 
PFA at 4ºC, dehydrated, and embedded in paraffin wax for sectioning. 4-6μm sections were used 
in all experiments. WT1 antibody (ab89901) was used at 1:300 dilution and incubated overnight 
at 4ºC. Following washes, a Don anti-Rabbit Alexa Fluor 594 (1:200) secondary antibody was 
applied for 1hr at room temperature and counter stained with Hoecsht 33342. Commercial 
antibodies are VIM (Abcam ab92547 1:500), CK8 (ab53280 1:100), CK5 (ab24647 1:750), and 
SMA (ab7817 1:75, ab5694 1:1000) with secondary antibodies (from Thermo-Fisher Scientific), 
Goat anti-Rabbit IgG, Alexa Fluor 488, A-11008 1:200 and Goat anti-Mouse IgG, Alexa Fluor 
568, A-11004 1:200. 
 
4.2.2 Mice and Lineage tracing 
B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J (ZsG) reporter mice (Madisen et al., 2010), 
Wt1tm1(EGFP/cre)Wtp (Wt1:Cre) (Zhou et al., 2008) knock-in allele, Wt1flox (Martinez-Estrada et al., 
2010) conditional Wt1 mutant allele, Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo (mt/mg) 
(Muzumdar et al., 2007) reporter allele, and Tg(Pbsn-cre)4Prb (Pb:Cre4) (Wu et al., 2001a) 
transgenic allele were all maintained by crossing to C3H/HeJ x C57BL/6J hybrid mice. All animal 
care and procedures in this study were carried out under strict adherence to the Guide for the Care 
and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved 
by IACUC with protocol #15245 at the University of Illinois. For timed pregnancies vaginal plugs 
were checked in the morning after mating and noon was taken as E0.5. Genomic DNA was 




Total RNA was collected by homogenizing tissues in Invitrogen Trizol reagent. RNA was DNase 
I treated with NEB DNase I and cleaned on Zymo Research RNA Clean & Concentrate 25 
columns. NEB M-MULV reverse transcriptase was used to generate cDNA. Primer sequences 
were obtained from PrimerBank (Wang et al., 2011) and validated prior to use. Primer sequences 
are listed in Table 4.1. An Applied Biosciences QuantStudio Flex 6 thermocycler was used for 
amplification. The delta-delta-Ct method was employed to establish quantity differences.  
 
4.2.4 ChIP-seq experimentation and analysis 
UGS at appropriate age was dissected and disaggregated using the dunce homogenizer. Nuclei 
were isolated, chromatin was fragmented, and a rabbit polyclonal antibody raised against 
acetylated WT1 (sc-192) was used to precipitate chromatin. After ChIP, immunoprecipitated DNA 
checked for quality, then used to prepare libraries that were sequenced with an Illumina HiSeq 
2500 sequencer. For detailed protocol please refer to (Saul et al., 2017). Sequence data were 
mapped with Bowtie 2 (Langmead and Salzberg, 2012) to the UCSC Mus musculus mm9 genome 
using default parameters, then analyzed for peaks using MAC2 (Zhang et al., 2008a). MEME-chip 
(Machanick and Bailey, 2011) was used to analyze the binding motif. 
 
4.2.5 RNA-seq experimentation and analysis 
Whole UGS were dissected out at postnatal day 1 (P1) and postnatal day 4 (P4). 3 wildtype and 3 
Wt1-/+ mutants were collected at each stage. RNA was purified using Trizol preparation and tested 
for quality in the Bioanalyser. RNA-seq libraries were made using Lexogen’s QuantSeq 3’ mRNA-
Seq Library Prep Kit using the standard conditions. The library was sequenced in Illumina’s HiSeq 
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2500 and 5-10 Mil reads were generated per samples. Reads were mapped to mm10 using 
Lexogen’s Bluebee genomic platform with mapping efficiencies of 85-90%. The edgeR package 
from Bioconductor (Robinson et al., 2010) was used to find differentially expressed genes using 
default pairwise analysis. DAVID was used to find functional categories (Huang et al., 2009).   
 
4.3 RESULTS 
4.3.1 Wt1 is expressed in the mesenchyme and transitions into the epithelium of the 
developing UGS 
Wt1 has previously been reported to be expressed very highly in both the testis and ovaries of 
young and adult mice (Pelletier et al., 1991). Additionally, during kidney development WT1 
expression peaks between E17 and P3, after which it declines considerably by adulthood (Buckler 
et al., 1991). There have been no reports of expression of Wt1 in prostate development although 
RNA-seq data from our earlier experiments suggested expression of Wt1 transcripts in the 
developing UGS (Chapter 2). We thus decided to test expression of Wt1 RNA transcripts during 
development of the UGS. By using qPCR primers that differentiate between the -KTS and +KTS 
isoforms (Hammes et al., 2001), we investigated the expression patterns of these 2 major isoforms 
during prostate development. Our data showed that both isoforms are expressed during early UGS 
development, with the DNA binding -KTS isoform turning on at E16.5 and staying on until P7 
and the splicing factor +KTS isoform turning on at much higher levels at E14.5 and dropping in 
expression by P3 (Fig.4.1A).  
 
To identify cell types specific and spatial localization patterns of Wt1, we used an antibody raised 
against the WT1 protein that identifies all the isoforms of the gene and performed 
92 
 
immunohistochemistry. By E15.5, WT1 begins to appear in the dorsal mesenchyme, around the 
seminal vesicles and distal ventral mesenchyme in the UGS (Fig.4.1B). Expression is contained in 
nucleus at this stage (inset of Fig. 4.1B).  WT1 expression drastically increases by E18.5 in the 
dorsal mesenchyme proximal to the urethra, with lower expression in the ventral mesenchyme 
(Fig.4.1C). The emerging prostatic buds also begin expressing WT1 at the tips (Fig.4.1C). 
Expression persists in the condensing mesenchyme around the prostatic buds at P4, but expression 
in the buds is significantly higher at this stage (Fig.4.1D). The mesothelial lining the UGS also 
expresses WT1 at high levels (arrow in Fig. 4.1D). By P13, expression in the mesenchyme and 
epithelium is considerably reduced, and WT1 is confined to the periprostatic adipose cells (arrow 
in Fig. 4.1E). Expression of WT1 in adults persists in the adult prostate within the pelvic ganglia, 
which supply autonomic innervation to the tissue (Wiese et al., 2012a, Georgas et al., 2015). At 
this stage, WT1 protein expression is speckled in the nucleus, a pattern characteristic of proteins 
related to splicing and not of transcription factors (Fig.4.1F). Previous studies of this speckled 
pattern of expression of WT1 points to the +KTS isoform, which largely performs RNA-binding 
and splicing roles (Larsson et al., 1995, Davies et al., 1998). Together these data indicate that WT1 
expression transitions from the mesenchyme to the epithelium in the early neonatal stages of UGS 
development where it is localized to the nucleus and likely performs transcription factor functions 
and stays on in the +KTS form as an RNA-binding splicing factor.  
 
4.3.2 WT1+-Lineages transition primarily into prostate epithelium in adults 
Using a Cre-lox based strategy we tracked the fates of WT1+ precursor cells over developmental 
time. A Cre “knock-in” into the Wt1 endogenous loci (Wt1:Cre) (Martinez-Estrada et al., 2010) 
promotes recombination in a Rosa-ZsGreen reporter allele- Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze 
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(Madisen et al., 2010), hence called ZsG, and turns on the expression of a GFP construct. By 
tracing GFP expression in cells together with antibodies for marker proteins, we can identify the 
fates of these cells. At P4, when WT1 is still being actively expressed, the lineages labeled by the 
Wt1:Cre allele closely follow the real-time expression (Figs. 4.2A and 4.1D). At P7, when real-
time expression of WT1 is reduced in the epithelium and mesenchyme, Wt1:Cre labeling is still 
observed strongly in both these compartments (Fig.4.2B).  
 
The prostate develops and differentiates until the animal reaches sexual maturity. Therefore, to 
discover the ultimate identities of WT1+ precursors, we tracked lineages 8 weeks of age (Figs. 
4.2C-J). The strongest labeling of WT1+ lineages in these adult animals was observed in the 
epithelium of the prostate (Figs. 4.2C and 4.2E). Luminal cells marked by cytokeratin 8 (CK8) in 
the epithelium are the major functional component of the mature prostate epithelium and serve to 
secrete the necessary proteins into the seminal fluid (Donjacour and Cunha, 1988, Donjacour et 
al., 1987, Cunha et al., 1987). Basal cells marked by Cytokeratin 5 (CK5), on the other hand, have 
regenerative potential and play critical roles in maintaining ductal integrity and survival of luminal 
cells (Kurita et al., 2004). WT1+ precursors were observed to contribute significantly to both cell 
types, with a large percentage differentiating into luminal cells (Figs. 4.2C and 4.2E).  
 
4.3.3 WT1+-Lineages are present in all three lobes and in extra-prostatic tissues 
The adult prostate stroma is composed of fibroblasts and smooth muscle cells, both of which are 
important for regulating tension for prostate function (Cancilla et al., 2001, Cunha, 2008, Hayward 
et al., 1996b, Staack et al., 2003, Sugimura et al., 1986). Lineage tracing analysis showed that 
WT1+ cells differentiate primarily into the fibroblasts and not into smooth muscle cells (Figs. 4.2D 
94 
 
and 4.2F), even though WT1+ lineages have been reported in both the smooth muscle and 
fibroblasts in the epicardium (Zhou et al., 2008, Takeichi et al., 2013). The descendants of WT1+ 
cells were highly represented in all 3 lobes of the prostate: Dorso-lateral, Ventral and Anterior 
(Fig. 4.3). 
 
The closely apposed, extra-prostatic region contains important cells types that provides support 
and hormonal regulation during prostatic development. For example, the pelvic ganglia, located 
very near the dorsolateral prostate lobes, supply autonomic nervous innervation that is critical for 
control of prostatic growth and function (Georgas et al., 2015, Wiese et al., 2012b). We detected 
strong Wt1:Cre labeling in the neurons of the pelvic ganglia (Fig.4.2G), where real-time 
expression of WT1 protein also persists as cytoplasmic speckles into adulthood (Fig.4.1F). 
Furthermore, the rhabdosphincter, a striated skeletal muscle type that develops around the urethra 
just below the bladder neck, is crucial for keeping urinary continence (Rasouly and Lu, 2013). 
This muscle has an unusual origin in the sphlancnic mesenchyme, and is hypothesized to trans-
differentiate from the smooth muscle of the prostate (Borirakchanyavat et al., 1997). As in other 
muscle types, a niche of satellite cells is thought to represent stem cells responsible for post-natal 
growth and regeneration of myofibers (Relaix and Zammit, 2012). Wt1:Cre labeling was observed 
strongly in the satellite cells in this muscle (Fig. 4.2H), suggesting a novel role of the gene in 
regeneration of rhabdosphincter muscle cells. Finally, Wt1:Cre also labeled adipose cells 
surrounding the prostate, both the white fat (Fig. 4.2I) as well as the denser brown fat (Fig. 4.2J). 
This comes with no surprise as Wt1’s role in contributing cells to white adipose fat depots has been 




4.3.4 Conditional loss of Wt1 in the prostate, results in defects in the dorso-lateral and 
ventral lobes 
Our next goal was to analyze the effects of Wt1 loss of function (LOF) on prostate development.  
As a first step, we examined the possibility that haploinsufficiency of Wt1 would be associated 
with a phenotype by examining prostate structure in Wt1 heterozygous (Wt1-/+) mice. Indeed, the 
prostate of Wt1-/+ adult mutants showed mild defects in the dorso-lateral and anterior lobes (data 
not shown). This suggested Wt1 knockout is dominant or semi-dominant, and that probing a 
homozygous mutant would reveal a more severe prostate phenotype. Since null mutations of Wt1 
(Wt1-/-) lead to embryonic lethality at E12-15 (Agrawal, 2018) and as expression of WT1 in the 
prostate starts only after embryonic day 16 (Fig. 4.1) we were unable to use the complete LOF 
allele to test prostate function. Therefore, we generated prostate specific mutants of Wt1, using a 
well-tested prostate specific Cre driver, PB:Cre4 (Wu et al., 2001a), in combination with a loxP-
flanked (“floxed”) conditional Wt1 allele (Martinez-Estrada et al., 2010). Animals of the genotype 
Pb:Cre4+, Wt1flox/flox are conditional Wt1 homozygous mutants of the prostate that survive to 
adulthood. 
 
The prostates of the Pb:Cre4+, Wt1flox/flox animals were collected at 8wk and sectioned in the 
proximal-distal axis with respect to the urethra. To examine histo-pathology of the tissue, we 
performed hematoxylin and eosin stains on the sections (Fig. 4.4). The wild-type prostate at this 
stage has completed development and has started secreting proteins into the seminal fluid. The 
epithelial cells form a single cell layer along the basement membrane and in the dorsolateral lobe 
contain infolds and convolutions (Fig. 4.4A), while in the ventral lobe the epithelial layer is more 
96 
 
uniform and continuous (Figs. 4.4C and 4.4E). The stroma, containing fibroblasts and smooth 
muscle cells, forming a thin, continuous layer surrounding the epithelium.   
 
In PB:Cre4+, Wt1flox/flox animals, the epithelium in the dorso-lateral lobe displays a complete loss 
of structure including loss of infolds (Fig. 4.4B). The ventral lobe displays an even more severe 
phenotype, where the single-cell epithelial structure is lost, and cells form multilayered, 
disorganized structures (Figs. 4.4D, 4.4F and 4.4G). The ventral prostate in the mutants also 
contain cells inside the gland (arrow in Fig. 4.4G). Additionally, the rounded circumference seen 
in the wild-type ventral prostate (Figs. 4.4C and 4.4E) is lost, and the PB:Cre4+, Wt1flox/flox ventral 
prostate displays more angular edges (Fig. 4.4D). 
 
4.3.5 Over-proliferation of luminal epithelium in PB-Cre4+, Wt1flox/flox prostate 
To identity the epithelial cells affected in the ventral prostate, we carried out immuno-
histochemical stains of proteins markers for different cell types. The stroma of the mutant was 
normal with fibroblasts and smooth muscle cells in correct numbers and patterns (data not shown). 
However, the luminal cells in the epithelium were increased in number and were growing in 
disorganized multilayer structures (arrowhead in Figs. 4.5C and 4.5D). The cells observed inside 
the ventral ducts were also identified as luminal cells (arrow in Figs. 4.5C and 4.5D). This is 
indicative of both over-proliferation and detachment of luminal cells in the mutants. The mature 
prostate does not proliferate after sexual maturity, except in diseased states like benign prostatic 
hyperplasia and prostate cancer, where epithelial cells acquire the ability to divide (Evans et al., 
1997, Evans and Chandler, 1987, Greenberg et al., 1995). A very similar phenotype of the ventral 
prostate is seen in mice lacking epithelial Androgen Receptor (AR), where the prostate tissue 
97 
 
becomes hyperproliferative relative to wild-type; in addition, in these AR- animals, luminal cells 
are observed suspended in the prostatic secretions (Wu et al., 2007). In these AR-knockout 
animals, CK8 expressing luminal cells over-proliferate, then undergo anoikis (Reddig and Juliano, 
2005) by detaching from the basement membrane and floating inside the lumen (Wu et al., 2007). 
The floating epithelial cells seen the PB-Cre4+, Wt1flox/flox prostate might have a similar fate, which 
can be probed by TUNEL assays. Our results thus demonstrate a key role for Wt1 in the 
development of the epithelium and in controlling proliferation in this cellular compartment, 
ensuring that the luminal epithelium forms a single cell layer along the basement membrane and 
does not continue to proliferate after differentiation. Wt1 could act in one of two ways control the 
number of cells: it could negatively regulate cell division, or actively promote apoptosis. To test 
the first hypothesis, proliferation markers like BrdU incorporation assay and PCNA staining are 
planned; and to test the second hypothesis TUNEL staining is planned.  
 
4.3.6 Increase in mesenchymal cell density at post-natal day 4 in PB-Cre4+, Wt1flox/flox UGS 
The phenotype of the PB-Cre4+, Wt1flox/flox adult prostate indicated a very important function for 
Wt1 during prostate development. Our results indicated that Wt1 is expressed early during UGS 
development, beginning around embryonic day 16.5 (Fig. 4.1). To identify early roles of Wt1 
during prostate development and to pinpoint when a phenotype is first seen, we examined UGS 
and prostate structure in younger mutant animals, beginning at the early postnatal stages when 
prostate development is first fully underway.  
 
We observed no obvious differences between mutant and wild type animals immediately after 
birth, at P1. However, at post-natal day 4 (P4) we observed an increased cell density in the 
98 
 
mesenchyme in the ventral lobe of the PB-Cre4+, Wt1flox/flox UGS (Figs. 4.6B and 4.6D). To 
quantify the increase in cell density, we counted the mesenchymal cells in a defined region, and 
divided it by the surface area of the region in µm2. We used 2 animals of each genotype and 
averaged 5 regions per animal. The mesenchymal cell density in the PB-Cre4+, Wt1flox/flox mutants 
was significantly higher, with cell numbers twice that of the age-matched wild-type mice (Fig. 
4.6E). At this stage of UGS development, the epithelial buds have started to elongate and undergo 
massive branching morphogenesis, surrounded by a sheath of mesenchymal cells that differentiate 
into the periductal stroma (Sugimura et al., 1986, Grishina et al., 2005, Cunha, 2008). Also at this 
stage, WT1 protein is present both in the epithelium and in the mesenchyme (Fig. 4.1D), although 
lineage tracing with the Wt1:Cre labels cells primarily in the mesenchyme at this stage (Fig. 4.2A). 
This suggests a slight delay in the Cre-driven ZsGreen expression during the lineage tracing 
assays.  
 
Key signaling interactions between the epithelial and mesenchymal compartments are crucial and 
important for growth and development at this stage, as has been well documented over the years 
(Cunha, 1994, Cunha, 1996, Cunha, 2008, Freestone et al., 2003, Grishina et al., 2005, Hayward 
et al., 1996b, Sugimura et al., 1986). Therefore, it is possible that the increase in mesenchymal cell 
density in the PB-Cre4+, Wt1flox/flox mutant could contribute to the over-proliferation in epithelial 
cells at later stages (Figs. 4.4D, 4.4F and 4.4G) via mesenchymal-epithelial signaling. For 
example, the UGS mesenchyme secretes key morphogens like BMP-4, FGF-10, TGFβ and Shh 
target genes (Donjacour et al., 2003, Hayward et al., 1998, Lamm et al., 2001, Raghow et al., 1999, 
Bushman, 2016), which regulate both epithelial and mesenchymal proliferation and 
differentiation. We hypothesize that Wt1 may act upstream of these key pathways and thus affect 
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both the epithelium as well as the mesenchyme development. However, as the stroma does not 
display a phenotype in the adults, it is unclear what happens to the excessive mesenchymal cells 
from P4. It is possible that the extra cells undergo apoptosis and equalize in number later during 
development. Experiments with TUNEL assays to detect apoptotic cells have been planned to 
answer this question.   
 
The PB-Cre4+, Wt1flox/flox mutant is a conditional knock-out, and not a complete ablation, with the 
Pb:Cre4+ transgene driving the knockout of Wt1 in only the cells that express the Probasin 
construct. To truly identify the cells Pb:Cre4+ transgene is expressed and thus where Wt1 is 
ablated, we used the Pb:Cre4+ allele together with the mTmG and ZsGreen reporters to identify 
Pb:Cre4+-associated lineages. At P0 and P1, reporter expression is uniformly distributed 
throughout the mesenchyme (Figs. 4.7A and 4.7B). In contrast, in adults the expression is detected 
primarily in the epithelial cells of the prostate (Figs. 4.7C and 4.7D). There is no expression of this 
transgene in the extra-prostatic tissue like the pelvic ganglia (Fig. 4.7 E), rhabdosphincter or 
adipose cells (data not shown). Thus the Pb:Cre4+ construct follows a very similar expression 
pattern as Wt1 in the prostate per se, with expression shifting from the mesenchyme to the 
epithelium during development. The expression of this Cre construct does not coincide with Wt1 
outside the prostate proper, making it an excellent tool for prostate-specific Wt1 ablation. 
Therefore, we can be confident that the loss of Wt1 expression in the mesenchyme or subsequently, 






4.3.7 WT1 ChIP-seq at postnatal day 4 (P4) reveals multiple binding sites in the genome 
As mentioned, WT1 nuclear protein acts as a transcription factor. To identify regulatory targets of 
WT1, we performed ChIP-seq with a validated antibody for WT1 (sc-172) (Motamedi et al., 2014, 
Kann et al., 2015) on chromatin prepared from the developing UGS at P4. This developmental 
time-point was picked because expression of WT1 is high in the nucleus and a clear phenotype 
was seen in the PB-Cre4+, Wt1flox/flox. Two independent biological replicate ChIP experiments were 
carried out with highly reproducible results. After mapping reads using bowtie2, peaks were called 
using MACS2, using a very similar pipe-line used by others analyzing WT1 ChIP in other tissues 
(Motamedi et al., 2014) and (Kann et al., 2015). Irreproducible Discovery Rate (IDR) analysis 
(Zhang et al., 2017) was carried out between the replicates and an IDR cutoff of <0.1 yielded 3039 
peaks (Fig. 4.8A, Suppl table 4). Using peaks below this IDR cut off, MEME-ChIP analysis 
identified a highly enriched motif (E-value = 4.9e-024, Fig. 4.8 C) with significant similarity to 
previously published WT1 ChIP-seq motifs (Motamedi et al., 2014, Kann et al., 2015).  
 
We next mapped WT1 binding sites with respect to the TSS of the associated genes. Interestingly, 
20% of the WT1 binding sites were 5kb of the TSS, 35% were within the 5-50kb, but more than 
45% were between 50-500kb of the nearest TSS (Fig. 4.8 B). This result suggests that WT1 works 
mostly through distal regulatory elements by complex looping patterns instead of directly binding 
to promoters and regulating gene transcription. Similar results have been observed in kidneys for 
WT1 binding (Motamedi et al., 2014, Kann et al., 2015). 
 
Genomic Regions Enrichment of Annotations Tool (GREAT) analysis (McLean et al., 2010) was 
used to perform functional annotation of the peaks below the IDR<0.1. The top two categories 
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enriched in genes associated with WT1 UGS ChIP peaks were cellular senescence and regulation 
of SMAD proteins (Fig. 4.8 D). Cellular senescence is a phenomenon which causes cell cycle 
arrest, a phenomenon that provides protection against cancer in addition to other cellular functions 
(Hayflick and Moorhead, 1961, Bodnar et al., 1998). Wt1 has a known role in regulating 
senescence (Vicent et al., 2010), and the over-proliferation of cells that we see in the mesenchyme 
and epithelium could be due to loss in senescence in the mutants. The SMAD proteins are effector 
molecules downstream of the TGF-β/BMP signaling pathway (Miyazono, 2000, Wrana and 
Attisano, 2000), and they play a key role in prostate development (Itoh et al., 1998, Lamm et al., 
2001, Grishina et al., 2005). This pathway has shown to be important in prostate ductal 
morphogenesis and epithelial proliferation (Lamm et al., 2001). BMP1 and BMP7 are associated 
with peaks in the WT1 ChIP-seq experiment, and BMP7 has clear links to inhibit prostate ductal 
budding and branching morphogenesis (Lamm et al., 2001, Grishina et al., 2005). This strongly 
suggest that Wt1 is upstream of the TGF-β/BMP pathways during prostate development and 
regulates the growth of the tissue by mediating the signaling between the epithelium and 
mesenchyme through this pathway.  
 
We next compared our ChIP-seq data to previously published ChIP-seq data on E18.5 kidneys 
(Motamedi et al., 2014). There was very low overlap of peaks between these two data sets (Fig. 
4.8 E) suggesting that WT1 binding largely depends on tissue context. This property of WT1 has 
is well known, and its highly dynamic function in different tissues has led to the identification of 
novel roles in different cell types (reviewed by (Hastie, 2017)). In addition, we compared the 
genomic annotations of the peaks in the P4 UGS ChIP-seq with the E18.5 kidney peaks and we 
saw that the majority of the peaks were present in intergenic regions of the genome (Fig. 4.8 F). 
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Again, this suggested that Wt1 affects gene expression indirectly through distal enhancers instead 
of directly binding to promoters and affecting transcription.    
 
4.3.8 Wt1-/+ RNAseq at postnatal day 4 (P4) reveals dysregulation in the differentiation of 
fat and muscle 
WT1 ChIP-seq revealed multiple peaks distributed in the genome (Supp 3). But the doesn’t 
guarantee that genes associated with these peaks would be transcriptionally affected. To identify 
the effects of WT1 LOF on gene expression in the UGS, we first performed 3’ end RNA-seq on 
Wt1-/+ UGS at P1 and P4. At P1 Wt1 was not detected as being significantly differentially 
expressed in the heterozygous animals, with less than 30 other genes that were significantly 
different in the mutant (Supp 3). This suggests that at P1 the loss of one allele is compensated by 
a possible up-regulation of the other and since Wt1 is not differential regulated we can’t predict if 
it the gene has an impact in UGS at this time-point. 
 
In contrast, at P4, Wt1 was detected as being down-regulated by a fold change of 0.66 (Supp 4) in 
Wt1-/+ UGS, consistent with the heterozygous ablation of the gene in the UGS at this stage. In 
addition to Wt1, 112 genes were down-regulated with a logFC<-1.5 and 197 genes were up-
regulated with a logFC>1.5 (Fig. 4.8). DAVID (Huang et al., 2009) was used to perform functional 
clustering of these genes to look for enrichment in biological terms and pathways. In the down-
regulated category, terms associated with adipose development, such as brown fat cell 
differentiation, regulation of lipolysis, and white fat differentiation were enriched; in the up-
regulated category, terms associated with muscle development and function including muscle 
proteins, Z disc, and muscle contraction were enriched. These seemly apposed pathways are 
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regulated in opposite directions in the heterozygous mutant, suggesting that Wt1 is involved in the 
switch between differentiation of mesenchymal cells into one path or the other.  
 
This RNA-seq data needs to be considered in the context of Wt1 activity in the whole tissue sample 
and cannot fully explain the phenotypes we see in the PB-Cre4+, Wt1flox/flox mutants. The Wt1-/+ 
animals have global heterozygous ablation of the gene, thus the knock-down of this TF is 
uniformly present in all cell types, including the extra-prostatic tissues;  as mentioned, WT1 
expression is seen in the fat, pelvic ganglia and also in the satellite cells of the rhabdosphincter, 
and these tissues could easily contribute to gene expression differences associated with global KO 
(Figs. 4.1 and 4.2). However, Pb:Cre4 transgene is limited to the developing prostate per se and 
hence Wt1 is not ablated in fat or muscle of  Pb-Cre4+, Wt1flox/flox mutants. To really understand 
the Pb-Cre4+, Wt1flox/flox phenotype, RNA-seq studies are in progress with P4 animals of this 
genotype to be compared to the WT1 ChIP-seq at this stage. 
 
4.4 DISCUSSION 
WT1 is a multi-functional and dynamic protein; mutations of this gene are associated with 
pediatric kidney cancer, leukemia, gonadal dysgenesis and heart disease to name a few (Hastie, 
2017). Additionally, Wt1 is a key regulator in several tissues during development, especially 
tissues that undergo a mesenchymal-to-epithelial switch. Wt1 function has been extensively 
studied in animal models, and its spatio-temporal expression and contributions to different cellular 
fates have been identified. WT1 has been implicated in prostate cancer and is often used as a marker 
for prostate cancer in human patients, where expression is re-activated (Devilard et al., 2006). 
However, a role for this well-studied protein in normal prostate development has not been reported, 
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and this study provides the first description of the expression and function of Wt1 in this tissue. 
Our study was aimed particularly to elucidate the developmental window in which WT1 acts 
during UGS development with a particular interest in the protein’s TF function, and to identify 
phenotypes associated with loss of function of the gene.  
 
Previous work from our lab was aimed at elucidating the role and function of the TF Tbx18 during 
prostate development. Since Tbx18 and Wt1 are known to act to interact during development of 
other tissues (Takeichi et al., 2013, Norden et al., 2012) our attention was piqued when RNA-seq 
data from E18.5 UGS indicated expression of the Wt1 transcript in this tissue and mis-expression 
in Tbx18 mutant mice (Bolt et al., 2016). Additionally, the Tbx18 mutant had a severe prostate 
phenotype, with pathologies extending into the epithelium, although Tbx18 expression is restricted 
to the mesenchyme (Chapter 2). This indicated disruption of key signaling pathways between the 
two compartments (mesenchyme-epithelium) in Tbx18 mutants and we probed the data to identify 
epithelial factors that could be driving the epithelial defect. Wt1 was a candidate that fit this role, 
and subsequent analysis did reveal significantly high expression of this gene in the epithelium.  
 
We started out by tracking the -KTS and +KTS transcripts during development using specific 
qPCR primers. Both transcripts begin to be expressed at around E16.5, just as the epithelium starts 
budding into the surrounding mesenchyme. Tracking WT1 protein levels with 
immunohistochemistry revealed early expression in the mesenchyme that transitions into the 
epithelium at around P4. In the adults, neurons in the pelvic ganglia continue to express the protein 




During the early neonatal stages when WT1 expression is high, most mesenchymal cells are 
undifferentiated and could follow multiple potential differentiation fates. To identify which types 
of cells WT1+ precursors are fated to become in adults, we used a Cre-lox strategy to perform 
lineage tracing with a Wt1:Cre knock-in allele (Martinez-Estrada et al., 2010). As determined by 
these experiments, in the prostate proper, WT1+ cells become the luminal and basal cells in the 
epithelium; in the stroma, WT1+ cells become fibroblasts.  In the extra-prostatic regions, WT1+ 
cells become neurons in the pelvic ganglia, satellite cells in the rhabdosphincter and white and 
brown adipocytes in the periprostatic fat pads. The dense mesenchymal expression of WT1 seen 
in the early stages, also including the “loose mesenchyme”, predominantly contribute to the extra-
prostatic tissues. WT1+ precursors have been demonstrated previously to develop into fat (Chau 
et al., 2014) and neurons (Wagner et al., 2002), but the differentiation of WT1+ precursors into 
satellite cells of the muscle is novel. The rhabdosphincter is a peculiar type of straited muscle type 
and has a very different lineage, derived from the splanchnic mesenchyme, compared to other 
straited muscle in the body. It is believed to transdifferentiate from the smooth muscle in the UGS 
(Borirakchanyavat et al., 1997). This special developmental history could explain the presence of 
WT1+ descendants in this particular muscle sub-type and not in other skeletal muscle in the body.  
 
After establishing expression patterns of WT1 during UGS development, we probed whether Wt1 
has roles in development and/or maintaining tissue homeostasis of the prostate. We used a 
conditional Wt1 knock-out (floxed) allele in combination with the Pb:Cre4+transgenic allele to 
ablate Wt1 specifically in the prostate. The Pb-Cre4+, Wt1flox/flox mutants survive to adulthood, and 
exhibit dramatic defects in the dorso-lateral and ventral lobes. First, the luminal epithelial cells 
over-proliferate in the ventral lobe; some cells get detached from the epithelial lining of the ducts 
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and end up floating in the secretions (Fig. 4.5). This phenotype is reminiscent of mutants in which 
the Androgen Receptor (AR) is knocked out in the epithelial cells of the prostate (Wu et al., 2007). 
This suggests that Wt1 could act upstream of the AR pathway, by regulating the AR gene either 
directly or indirectly. This hypothesis is supported by published data in other tissues.  For example, 
WT1 binds to the AR promoter and regulates AR expression in developing male gonads 
(Shimamura et al., 1997); and in kidney and sertoli cell lines (Zaia et al., 2001). However, it is 
important to note that activation or repression of target genes by WT1 largely depends on cellular 
context as illustrated by multiple studies (Menke et al., 1998, Reddy et al., 1995, Kim et al., 2009), 
which is further demonstrated by activation and repression of AR by WT1 in different cell lines 
(Kohler et al., 2007). Experiments investigating AR expression and localization in the PB-Cre4+, 
Wt1flox/flox mutant UGS and prostate are planned.  
 
It is possible that the epithelial disorganization that was seen in 12Gso/Tbx18- mutant prostate 
(Chapter 2) could be due to dysregulation of Wt1 in the epithelium of these animals. These data, 
along with the observation that Tbx18 is expressed prior to Wt1 in the UGS, suggests that Tbx18 
acts upstream of Wt1, and could directly regulate Wt1 in the mesenchyme, and/or possibly 
indirectly, through mesenchymal-epithelial signaling, in the epithelium. But as the epithelial 
defects seen in 12Gso/Tbx18- are distinct from those observed in the Pb-Cre4+, Wt1flox/flox, 
understanding the relationship between these two genes in prostate development will require 
further study.  
 
WT1 is well known to have different roles in the same cell types and tissue regions during 
developmental time, for example in the kidneys, if Wt1 is knocked out early there is apoptosis in 
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the cells, but slightly later repression prevents cells from differentiating into nephrons and causes 
proliferation instead (Davies et al., 2004). The authors attribute these differences to a different 
need of WT1 during kidney development, before and after the metanephros kidney mesenchyme 
undergoes condensation followed by epithelial transition. Interestingly, Wt1 plays a role as a tumor 
suppression and also an oncogene in different cellular and developmental context (Yang et al., 
2007, Loeb and Sukumar, 2002, Huff, 2011). It is likely that as TBX18 is expression before WT1 
in the developing UGS, Wt1 gets dysregulated in 12Gso/Tbx18- much earlier than in the Pb-
Cre4+, Wt1flox/flox animal, before its switch from the mesenchyme to the epithelium, and hence 
although both these animals have an epithelial defect caused by dysregulation of Wt1, they seem 
to show different epithelial phenotypes. 
  
To pin-point a developmental time-point during which WT1’s role becomes essential during UGS 
development, we examined prostates of neo-natal mice of PB-Cre4+, Wt1flox/flox mutants at 
different ages to identify the first occurrence of any phenotype. To our surprise, we saw increase 
in mesenchymal cell density to about 2-fold in the mutants at P4 (Fig. 4.6). P4 is an interesting 
developmental stage because it is the first stage that WT1 begins to be expressed in the epithelial 
buds after being confined earlier to the mesenchyme. An over-proliferative mesenchymal defect 
at P4 that turns into an over-proliferative epithelial defect in adults suggests a role for WT1 in both 
these compartments, but also suggests a possible role of this gene in mesenchymal-epithelial (M-
E) signaling. Expression of WT1 is high in the mesenchyme and later in the epithelium, so it is 
possible that WT1 could controlling both these compartments independently, as seen in other 
tissues where it has distinct functions at different time-points (spatio-temporal regulation (Davies 
et al., 2004)). But it is also possible, as expression of WT1 starts out in the mesenchyme and then 
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moves into the epithelium, a pattern reflected in the phenotype of PB-Cre4+, Wt1flox/flox mutants - 
with mesenchymal over-proliferation followed by later proliferation of the epithelium. Several 
genetic regulators and signaling pathways act between the epithelium and mesenchyme 
compartments, and play critical roles in prostate development, including Hox genes, Nkx3.1, and 
the Hedgehog (Hh), fibroblast growth factor (FGF), WNT, NOTCH, and transforming growth 
factor-β/bone morphogenetic protein (TGFβ/BMP) and androgen signaling pathways (Prins and 
Putz, 2008, Montano and Bushman, 2017). Wt1 could be upstream any of these pathways thus 
regulating the interactions between the M-E compartments. To probe pathways and genes Wt1 
may regulate, we used functional genomics and NGS based methods to investigate.   
 
Using WT1 ChIP-seq performed at P4 in the UGS, we determined in vivo binding sites of this TF 
in the genome. Expression of WT1 at this stage is nuclear and in both the mesenchyme and the 
epithelium. We found 3039 binding sites of WT1 that were enriched in intergenic regions of the 
genome. This is consistent with binding patterns of the gene in other tissues (Motamedi et al., 
2014, Hartwig et al., 2010), suggesting indirect role of the gene in transcription regulation by 
interacting with regulatory elements instead of promoters of genes (Fig. 4.8). Cellular senescence 
and regulation of SMAD proteins were highly enriched functional categories from the genes that 
were associated with the peaks. WT1 has been known to regulate cellular senescence in KRAS-
driven oncogenesis in lung cancer (Vicent et al., 2010) and is upstream to the BMP-pSMAD 
Pathway in renal progenitors (Motamedi et al., 2014). Thus, the function of Wt1 in UGS 
development seems to be upstream of the same pathways in other tissues, although the prostate 
phenotype we see is novel. However, the Wt1-/- phenotypes seen in the kidney is very reminiscent 
of the prostate defect. WT1 expression increases in the metanephric mesenchyme as it undergoes 
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epithelial transition (Armstrong et al., 1993) and in Wt1–/– embryos, the mesenchyme becomes 
apoptotic and the outgrowth of the ureteric bud does not occur (Kreidberg et al., 1993). 
Additionally, repression of Wt1 transcripts in the kidney mesenchyme prevents cells from 
differentiating into nephrons and causes them instead to proliferate abnormally (Davies et al., 
1998). This phenotype may be due to a similar mechanism as that driving over-proliferation of the 
mesenchyme in Pb-Cre4+, Wt1flox/flox prostate.  
 
SMAD proteins are the effector proteins in the BMP/TGFβ signaling pathways and phosphorylated 
by TGFβ and activin receptors and propagate their specific signals, while other Smad proteins are 
activated by BMP receptors and mediate BMP signals. BMPs are members of the TGFβ gene 
superfamily and usually act as inhibitors of cellular proliferation (Hogan, 1996). In the P4 UGS, 
Bmp1, Bmp7 and Bmper all have WT1-associated peaks. Binding of WT1 to Bmp7 has been 
previously reported (Motamedi et al., 2014, Hartwig et al., 2010), and Bmp7 plays an inhibitory 
role in prostate development (Grishina et al., 2005). Specifically, Bmp7 is localized to the UG-M 
during the prostate initiation and then moves to the epithelium in post-natal life. It has an important 
role in controlling the epithelial branching by inhibiting proliferation of epithelial cells. Our data 
suggests that WT1 plays a key role in regulating Bmp7 expression in both M-E compartments, and 
through that mechanism curbs over-proliferation. 
 
Finally, we performed RNA-seq of Wt1-/+ UGS at P1 and P4 to determine other targets of the 
gene. At P1, we do not see down-regulation of Wt1 in these heterozygous animals (Supp 4). At P4 
however, we see a 0.66-fold-change of the Wt1 transcript and dysregulation of over 200 genes. 
This heterozygous ablation of the gene is global with knock-down even in the extra-prostatic 
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tissue, unlike the PB-Cre4+, Wt1flox/flox mutants. Upon performing functional annotation of genes 
that were dysregulated, terms relating to fat and muscle were enriched; these differentiation 
pathways were observed to be dysregulated in opposite directions in the mutants. This suggests 
that Wt1 acts at the stage of the undifferentiated mesenchymal cells where the cell have the 
potential to become muscle or fat. In the mutants the balance is tipped, and the data suggest that 
muscle and fat differentiation does not proceed normally. Although the phenotype in PB-Cre4+, 
Wt1flox/flox mutants cannot involve muscle or fat, these data suggest that Wt1 plays an important 
role in the differentiation of these extra-prostatic tissues. Conditional knockout of Wt1 in these cell 
types would better illustrate the role of gene in these differentiation paths. Indeed, a crucial role of 
WT1 in fat has already been established: when Wt1 is ubiquitously deleted in adult mice, there is 
rapid fat loss (Chau et al., 2011). RNA-seq of the PB-Cre4+, Wt1flox/flox mutant UGS is also planned 
to further explain the over-proliferative phenotype we see in those animals. Additionally, the RNA-
seq would also include functions of the RNA-binding isoform, while ChIP-seq would only predict 
DNA binding transcriptional control functions, suggesting the fat and muscle differentiation role 
is carried out by the +KTS isoform.  
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4.5 TABLE AND FIGURES 
Name Strain Sequence 
Pbsn-Cre_F PB:Cre4 ctgaagaatgggacaggcattg 
Pbsn-Cre_R PB:Cre4 catcactcgttgcatcgacc 
Cre-UP Wt1:Cre ATGTCCAATTTACTGACCGT 
Cre-Down Wt1:Cre CGCCGCATAACCAGTGAAAC 
oIMR9020 ZsGreen AAG GGA GCT GCA GTG GAG TA 
oIMR9021 ZsGreen CCG AAA ATC TGT GGG AAG TC 
oIMR9103 ZsGreen GGCATTAAAGCAGCGTATCC 
oIMR9104 ZsGreen AACCAGAAGTGGCACCTGAC 
Wt1-Flox-F Wt1:Flox TGGGTTCCAACCGTACCAAAG 
Wt1-Flox-R Wt1:Flox GGGCTTATCTCCTCCCATG 
Wt1 (+/-KTS) 
F Wt1 GTGAAACCATTCCAGTGTAAAAC 
Wt1 (-KTS) R Wt1 GGG CTTTTCACTTGTTTTAC 
Wt1 (+KTS) 
R Wt1 GCCACCGACAGCTGAAGGGC 





Figure 4.1. Wt1 expression in the developing prostate. qPCR of isoforms of Wt1 transcripts 
indicate that both the +KTS and –KTS isoforms are expressed. The –KTS isoform (DNA binding) 
turns on at E14.6 increases at E16.5 and then gradually decreases with time. The +KTS isoform 






Figure 4.2. Wt1 lineages in the prostate. Using a Cre expressed by the endogenous Wt1 locus, 
Wt1:Cre and a reporter allele, ZsG, we were able to study the differentiation paths of WT1+ 
expressing cells. At early post-natal stages, Wt1 lineages are primarily in the mesenchyme of the 
prostate (A,B). At P4 there is some expression in the epithelium buds and the urethral epithelium. 
At P7 there is expression in the ventral prostate buds (arrow in B). In the adults, Wt1 lineages are 
present in the luminal cells marked by CK8 (C) and basal cells marked by CK5 (E). They are 
present in the fibroblasts marked by vim (F) and not in the smooth muscle cells marked by SMA 
(D) in the stroma. In the extra-prostatic regions surrounding the tissue, lineages are seen in the 






Figure 4.3. Lineages of WT1+ cells in seen in all 3 prostate lobes. WT1+ cells have equal 
representation in all three lobes of the prostate in the epithelium. In the stroma they don’t become 






Figure 4.4. Prostate defects in PB-Cre4+, Wt1 Flox/Flox at 8wk. Hematoxylin and Eosin stains of 
8wk prostate from PB-Cre4+, Wt1 Flox/Flox animals reveal over-proliferative ventral and dorso-
lateral epithelium. The dorso-lateral lobe has small glands with infolds and a single cell layer of 
epithelium lining the basement membrane in the wild-types (A). In the mutant, there is loss of the 
continuous structure and the cells have become hyper-proliferative (B). The ventral lobe in the 
wild-type has a continuous, single cell, smooth morphology of the epithelium cells, with a clear 
fluid inside the ducts (C,E). In the mutant, the epithelial cells have started growing on to of each 
other, and the smooth, continuous layer is lost (D,F,G). There are cells visible inside the ducts of 







Figure 4.5. Over proliferation of CK8 cells in ventral prostate of PB-Cre4+, Wt1flox/flox 
prostate at 8wk. Sections of the ventral prostate were stained with hematoxylin and eosin (A,C) 
and adjacent sections were stained with CK8, that marks luminal cells (B,D). The epithelial cells 
that grow on top of each other and stop forming a single cell layer as seen in the wild-type are 
luminal cells (arrow head in C,D). The luminal cells also detach and infiltrate into the prostatic 







Figure 4.6. Increase in mesenchymal cell density in ventral lobe in Pbsn-cre, Wt1flox/flox UGS 
at P4. Hematoxylin and eosin stains at post-natal day 4 of the UGS show increase in cell density 
in the mesenchyme in the in Pbsn-cre, Wt1flox/flox UGS. 2 animals at each genotype were measured. 
Regions in the ventral lobe were marked and mesenchymal cells were counted within. The cell 









Figure 4.7. Pb-Cre4+ lineages in neonatal and adult prostate. Using the mTmG and ZsGreen 
reporter the lineages of the Pb:Cre4+ transgene can be tracked to adulthood. At postnatal day 0, 
expression turns on in the mesenchyme of the developing UGS, with a uniform distribution across 
the tissue (A). This continues onto postnatal day 1 where the transgene is expressed highly in 
mesenchyme (B). In the adult prostate, Pb:Cre4+ transgene is high in the epithelium (C) in the 
ventral and dorso-lateral lobes (D). The extra-prostatic pelvic ganglia (E) has no expression (E). 







Figure 4.8. WT1 ChIP-seq at P4 UGS. Using 2 biological replicates, WT1 ChIP-seq was 
performed at P4 in the developing UGS. Using IDR cut off of 0.1, 3039 peaks were identified (A). 
45% of the peaks were found to be between 50-500kb away from TSS (B). Using MEME-Chip 
the top motif was found to be very similar to published WT1 motifs (C). GREAT analysis of ChIP-
seq peaks revealed genes associated with cellular senescence and SMAD protein import (D).  
Comparing the P4 UGS ChIP-seq peaks to published WT1 peaks in E18 kidneys revealed very 
low overlap (E). The genomic distributions of P4 WT1 ChIP-seq peaks and published E18 kidneys 





Figure 4.9. P4 Wt1-/+ RNA-seq. 3 wildtype, 3 mutants (Wt1-/+) taken at P4. 1232 genes were 
differentially regulated with FDR<0.1. Wt1 downregulated by logFC of -0.58 (0.66 fold change). 
We performed gene ontology on genes passing cut off of logFC 1.5. Terms that were 
downregulated were associated with fat and adipose tissue. Terms that were up regulated were 













CONCLUSIONS AND FUTURE DIRECTIONS 
The T-box transcription factor Tbx18, is expressed early in embryogenesis and is important to the 
development of multiple mesenchymal-derived tissues. Homozygosity for the complete loss-of-
function allele (Tbx18-/-) is lethal at birth, with mutant animals displaying severe defects of the 
axial skeleton, kidneys, ureter and inner ear. This thesis describes expression of this gene in 
prostate development and a novel functional role in this tissue, originally discovered through 
systematic analysis of histo-pathologies of an unusual translocation mutant, 12Gso and confirmed 
using conditional deletion of Tbx18 using a prostate-specific cre. This was followed by lineage 
tracing approaches to identify the cell fates of TBX18+ cells, combined with chromosome 
conformature capture (4C) to identify regulatory elements driving the expression of Tbx18 in 
particular cell fate paths. Finally, the zinc finger transcription factor Wt1, a gene that was 
dysregulated in the Tbx18-/- mutant prostates, was identified to play a crucial role in prostate 
development downstream to Tbx18, a role that has never been described before.   
 
The 12Gso translocation mutant was generated in the Oak Ridge National labs in chemical 
mutagenesis experiments conducted with bis-acrylamide. The homozygous 12Gso/12Gso mutant 
had a very distinct phenotype with a shortened body, bifid ribs and often a kinked tail; cytological 
examination followed by molecular analysis identified the breakpoints, one located in an intergenic 
region of chromosome 9 (Bolt et al., 2014). Tbx18 was the closest gene to the 12Gso breakpoint, 
75kb away, and further investigation revealed that 12Gso was in fact a hypomorphic allele of 
Tbx18, with lowered expression of this gene in the developing embryo. Additionally, a 4.5kbp 
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highly conserved sequence around the breakpoint was shown to be an enhancer for the gene called 
ECR1, driving expression of Tbx18 in the urogenital tract (Bolt et al., 2014).  
 
A few 12Gso/Tbx18- mice survived to adulthood enabling us to study, for the first time, long term 
effects of the loss of Tbx18, which had not been possible before, due to neonatal lethality of Tbx18-
/-.  Chapter 2 of this thesis describes the severe defects in the prostate of 12Gso/Tbx18-, where a 
hyper-proliferative epithelium and a stroma displaying a myofibroblastic phenotype can be 
attributed to Tbx18 loss-of-function. Using a prostate specific transgene Pb:Cre4+, we were able 
to conditionally knock-out Tbx18 and recapitulate the prostate phenotype of the 12Gso/Tbx18- 
mice. Our studies showed that expression of Tbx18 in the UGS began early in the undifferentiated 
mesenchyme and our data suggested that the stromal defects in adult prostate of the Tbx18 
knockouts was due to the loss of proper differentiation of these cells. Instead of becoming 
fibroblasts and smooth muscle, the cells were trapped in the intermediate state of myofibroblasts.  
 
On the other hand, the epithelial phenotype was intriguing as Tbx18 is not expressed in this 
compartment; these data suggested dysregulation of mesenchymal-epithelial (M-E) signaling. 
RNA-seq analysis of Tbx18-/- at E18.5 revealed dysregulation of multiple epithelial factors like 
Hoxd13, Shh, Bmp4, and Sox9 that could be driving the epithelial defect. Additionally, another 
interesting gene was highly dysregulated in the Tbx18-/- RNA-seq, the zinc finger transcription 
factor Wt1. This multi-facetted gene that regulates development of multiple tissues, very similar 




ECR1, the 4.5kbp enhancer that was identified to drive expression of Tbx18 in the urogenital tract, 
only explained expression of the gene in a subset of cells (Bolt et al., 2014). This suggested 
presence of other regulatory elements driving expression of the gene in additional cell types. To 
map this regulatory domain, we used circular chromatin confirmation capture (4C), and coupled 
this analysis with ATAC-seq data to narrow the locations of the active regulatory elements in 
embryonic day 18.5 (E18.5) UGS chromatin (Chapter 3). The data revealed dozens of active 
chromatin elements distributed throughout a 1.5 million base pair topologically associating domain 
(TAD). The TAD contained approximately 10 broad enhancer peaks with multiple ATAC-seq 
peak within them, including one peak that contained the ECR1 region (Negi et al., 2019).  
 
Continuing the investigation of regulatory elements of Tbx18 in chapter 3, we carried out lineage 
tracing studies with two Cre alleles: one carrying Cre as a knock-in to the endogenous locus, and 
another representing a Cre knocked into a 209 kb BAC transgene, carrying a subset of the Tbx18 
regulatory region closely surrounding the gene. Lineage tracing studies were done in adults and 
by comparing the cell fates of the two Cres, the regulatory domain could be divided in 2 broad 
domains. Lineages controlled by the 209kp BAC region were in smooth muscle, fibroblasts, and 
neuroendocrine cells in prostate; and satellite glia in the pelvic ganglia. Lineages controlled by 
regulatory elements outside the 209kp BAC, but within the 1.5Mb Tbx18 TAD were in skeletal 
muscle of the rhabdosphincter; blood vessels; and periprostatic adipose tissue. This chapter 
describes novel findings that Tbx18-expressing precursors develop into multiple cellular types in 
prostate and supporting tissues, including some cell types that had never been associated with 




Chapter 4 of this thesis is focused on the role of Wt1 in prostate development. WT1 is a 
multifunctional protein required for the development of the kidney, heart and gonads. We became 
interested in studying this gene because it was significantly dysregulated in Tbx18-/- UGS at 
E18.5. Expression studies reveal that WT1 was expressed highly in the mesenchyme early during 
UGS development from E16.5 and switches to the epithelium at P4. It continues to be expressed 
in the fat cells at P13, and in adults is expressed in the neurons of the pelvic ganglia. Lineages of 
WT1 in the extra prostatic regions were in satellite cells of the rhabdosphincter, white and brown 
fat. This unique and high expression of WT1 during prostate development raised questions about 
its function in this tissue. As Wt1-/- mutants don’t survive past E12.5, we generated conditional 
mutants by using the Pb:Cre4+ transgene to drive the knockout of Wt1 using a loxP flanked in the 
prostate. The epithelium of the Pb:Cre4+, Wt1flox/flox prostate displays an over-proliferative 
phenotype in adults; at P4 the mutants have increased mesenchymal cell densities. These 
phenotypes indicated an important function of WT1 in controlling cell proliferation during prostate 
development, and in both the mesenchymal and epithlelial compartments. 
 
To gain a deeper understanding of the molecular basis of these phenotypes, we performed WT1 
ChIP-seq at postnatal day 4 (P4) to identify genome wide binding sites of the TF (Chapter 4). We 
obtained 3039 highly reproducible peaks spread across the genome, with an enriched WT1 motif 
in 33% of the peaks. Majority of the peaks were in the intergenic regions of the genome suggesting 
an indirect role of WT1 in transcriptional regulation. Functional categories of the genes associated 
with the peaks gave an enrichment of the term “import of SMAD proteins into the nucleus”. SMAD 
proteins are the effectors molecules in TGFβ/BMP pathways, suggesting that WT1 is upstream of 
this pathway. Bmp7 has an associated WT1 ChIP-seq peak and has previously been implicated to 
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reduce proliferation by activating the inhibitory BMP pathway during epithelial branching 
morphogenesis during prostate development. This strongly suggested that WT1 promotes Bmp7 
expression, which then turns on the BMP pathway to keep epithelial proliferation under control. 
Overall, this chapter describes a novel role and function of Wt1 during prostate development and 
we were able to use histology and genomics in combination to elucidate this. 
 
Chapter 3 of this thesis briefly describes expression of Tbx18 and the enhancer element ECR1 in 
the neurons of the dorsal root ganglia (DRG). This, along with lineage of TBX18+ cells in the 
pelvic ganglia (described in chapter 3), has opened a very fascinating and highly relevant avenue 
of Tbx18’s role in neuronal differentiation and a possible role in their function. Our data indicates 
that the first instance of expression of Tbx18 is the DRGs are seen at embryonic day 12.5 (E12.5), 
when the neuroblasts are still dividing. The second wave of expression of Tbx18 comes on at 
E18.5, when the neuroblasts start to differentiate into mature neurons and satellite glial cells. A 
recent study where sc-RNA-seq was performed on cells derived from embryos from E9.4-E13.5 
(Cao et al., 2019), reveals expression of Tbx18 in multiple neural lineages, like sensory and 
excitatory neurons, suggesting expression of TBX18 in other kinds of neurons. Ultimately, most 
of the TBX18+ cells in the pelvic ganglia become satellite glia, not mature neurons, suggesting 
that Tbx18 controls the differentiation of the early precursor neuroblasts specifically into satellite 
glia, and this also seems to be the case in the DRG. This is also further demonstrated by preliminary 
data that show an increase in number of neurons in the Tbx18-/- mutants (data not shown).  
 
Our data also confirm that Wt1 is expressed in the neurons of the PG and the DRG. It is very 
possible that it could act synchronously with Tbx18 in these cell types, just as it does in the prostate, 
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epicardium, and other tissues (Takeichi et al., 2013). Future studies of this project will be aimed 
at studying this unique expression of Tbx18 in these neural lineages. 
 
Using the Tbx18:BAC-iCre transgene, described in Chapter 3, we were able to knock out the loxP-
flanked (“floxed”) endogenous Tbx18 gene, in cells that are regulated only by the enhancers 
contained in the 209kp BAC construct. To our greatest surprise, these Tbx18:BAC-iCre, 
Tbx18flox/flox animals survived to adulthood with severe kidney defects, identical to the defects that  
have been described for Tbx18-/- animals (Airik et al., 2010, Bussen et al., 2004, Bohnenpoll et 
al., 2013). An important and perplexing question then arose: why are Tbx18:BAC-iCre, 
Tbx18flox/flox animals able to survive while the Tbx18-/- do not? A possible explanation could be 
that a regulatory element/s outside the 209kb BAC might control expression of the gene in a certain 
cell type, that is associated with lethality in Tbx18-/- animals.  In this case, Tbx18 would be 
expressed normally in those crucial cells in the Tbx18:BAC-iCre, Tbx18flox/flox animals, permitting 
their survival. Tbx18 would be ablated in those crucial cells in the full knockout mice, rendering 
those animals nonviable.  So, the question remains: why do Tbx18-/- animals die? Which cell types 
are affected in the full KO animals that is not affected in the Tbx18:BAC-iCre, Tbx18flox/flox mice? 
A peculiar phenotype displayed by Tbx18:BAC-iCre, Tbx18flox/flox animals may provide a clue.  
These animals clasp their hind limbs close to the body even when moving, hardly using them for 
support. The hind limbs develop normally with all the right measurements and morphology in 
these mutants and the musculature appears intact.  Our hypothesis for this strange behavior is that 
the loss of expression of Tbx18 causes defects in the motor neurons in the spinal cord or sensory 





Through the work done in thesis, we were able to demonstrate novel roles of Tbx18 and Wt1 in the 
prostate and revealed expression of both these genes in novel cell types. These genes play 
important roles in keeping tissue homeostasis and raise questions about roles of in human prostate 
conditions. These early acting genes significantly contribute to adult prostate health illustrating the 
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APPENDIX A: SUPPEMENTAL INFORMATION 
 
Supplemental Table 1: Contains data used in chapter 2. First tab contains list of RT-qPCR 
primers used for validation of differential gene expression done in chapter 2. The primer sets listed 
were used to validate expression in individual E16.5 and E18.5 animals comprising a sequenced 
pool, with results reported in Fig. 2.7. Second tab contains differentially expressed genes from 
comparisons of mRNA from whole urogenital sinus (UGS) dissected from Tbx18Gfp/Gfp null 
embryos and wild-type littermates at E16.5 and E18.5, respectively (as designated in column A). 
Column B indicates genes assigned as being enriched in mesenchymal (M) or epithelial (E) UGS 
compartments by Blum and colleagues; only genes that were assigned unambiguously in that study 
are marked. Log2 fold change (column L) and other data columns were taken directly from the 
output of CuffDiff analysis, as described in section 2.2 in Materials and Methods. 
 
Supplemental Table 2: Contains data used in chapter 3. First- and second-tab list the 4C-seq 
peaks in replicates that are in contact with the Tbx18 promoter identified in chapter 3. These peaks 
were called using the HTStation software described in section 3.2 in Materials and Methods. The 
third and fourth tab contain ATAC-seq data done on E18.5 male UGS. Fifth tab contains list of 
primers used in chapter 3. 
 
Supplemental Table 3: Contains data used in chapter 4. First tab contains list of peaks from WT1-
ChIP-seq done at postnatal day 4 (P4) in the UGS from chapter 4. Peaks were called using MACS2, 
and a pipeline described in detail in section 4.2 in Materials and Methods. Second tab contains list 
of DEGs found in the Wt1-/+ mutants compared to the wild-type and the third tab are DEGs at P1.  
